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ABSTRACT
The biogenic amine

hy~othesis

of affective disorders

ascribes a functional depletion of neurotransmitters within
critical regions of the brain as either the cause or, at the
very least, a concomitancy of the depressive syndrome.

Much

indirect evidence has accummulated to suggest that the therapeutic effect of tricyclic antidepressants (TCA's) is mediated by their ability to block the re-uptake of physiologically released neurotransmitter leaving more neurotransmitter
available within the synapse to interact with the post-synaptic receptor, thereby correcting the posited functional depletion.
The evidence upon which the proposed mechanism of TCA's
therapeutic activity is based is largely indirect.

~ ost

of

the evidence comes from in-vitro studies of the ability of
tricyclics to block neurotransmitter uptake into either
brain slices, minces or preparations of pinched-off nerve
endings (synaptosomes).

The therapeutic response, however ,

cannot be demonstrated upon acute aQministration of these
drugs and clinically effective activity is usually not ob·served until after several weeks of chemotherapy.

The up-

take inhibitory characteristics which have been demonstrated
in-vitro, therefore, cannot explain the latency to the therapeutic effect.
A time-course for the effect of protriptyline administration upon n3 -l-norepinephrine (E 3 -l-NE) uptake into hypothalamic crude synaptosomal homogenate (CSH) was determined
iii

after acute, sub-acute and chronic treatment .

In addition,

the ability of a number of TCA's to block the uptake of
three biogenic amines, the catecholamines, norepinephrine
and dopamine, and the indoleamine, serotonin, was assessed
using a CSH in-vitro test system.
The results support the biogenic amine hypothesis as
well as the proposed mechanism of action of TCA's .

Uptake

blockade could be demonstrated after acute and chronic administration but not after sub-acute administration.

An

attempt to describe some of the characteristic effects of
individual TCA's as well as effects common to the class of
drugs was approached on the basis of predominant neurotransmitter influences.
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CHAPTER I:

INTRODUCTION

2

The biogenic

a~ine

hypothesis of affective disorders,

admirably and extensively reviewed by Baldessarini (1975),
was first proposed by Jacobsen in 1959 and popularized by
Schildkraut and Kety (1967).

The hypothesis developed from

observations of the effects of drugs upon emotionality and
the resultant biochemical changes produced by these drugs in
experimental animals.

Reserpine, once used widely in the

treatment of essential hypertension, produces depression in
a significant proportion of patients necessitating withdrawal of the medication.

Reserpine has also been shown to

drastically deplete levels of physiologically active biogenic
neurotransmitter amines within the brains of experimental
animals.

The biogenic amine hypothesis attributes lowered

levels or turnover of these amines as either the cause or,
at the very least, a concomitancy of the depressive syndrome.
Further support for the hypothesis comes from the
noted clinical antidepressant properties of a class of drugs
referred to as monoamine oxidase inhibitors ( MAOI).

Ipronia-

zid, an early member of the class, produced mood elavation
in patients being treated for tuberculosis.

Inhibition of

MAO, an enzyme which degrades biogenic amines within the
central nervous system (CNS), results in increased levels of
the amines.

Reviews of the support for the biogenic amine

hypothesis abound (Davis, 1970; Schildkraut, 1973; Leonard,
1975; Weil-Malherbe, 1972) and even some dealing selectively
with either norepinephrine (Schildkraut, 1965), dopamine
(McClure, 1973) or serotonin (Lapin and Oxenkrug, 1969) as
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the critical neurotransmitter exist.
Tricyclic antidepressants have been shown to be effective inhibitors of the primarily neurotransmitter-specific,
"hi-affinity", uptake process which many investigators
believe is responsible for the termination of activity of
physiological concentrations of neurotransmitter at the
synapse.

The ability of these antidepressants to block the

uptake of neurotransmitter from the synapse may result in
more neurotransmitter available within the synapse to interact with the post-synaptic receptor.

This property of the

drug would logically tend to reverse the effect of a lowered
level or lowered potency or, in terms of the biogenic amine
hypothesis, a functional depletion of neurotransmitter and
can account for a reversal of the depressive symptoms.
The onset of clinical antidepressant activity, however,
cannot be explained by correlations with antidepressant
plasma levels (Oswald, 1972).

A lag of several weeks of

treatment before antidepressant activity becomes apparent
has been reported in clinical trials of tricyclic antidepressant therapy (Hammer, et al., 1962; Asberg et al.,
1970).

Uptake studies to date deal primarily with in-vitro

effects of antidepressants and in doing so cannot uncover
any significant alterations in the drug effects on the uptake
systems which might be coincident with and possibly related
to the clinical antidepressant activity.

Although one

recent study (Ross and Renyi, 1975b) reports the effect of
uptake blockade in animals treated for one day orally, there

4
has not been a study reporting the effect of chronic administration of tricyclics on the hi-affinity uptake system of
biogenic amines in the central nervous system.

The design

of many antidepressant drugs and the animal screening models
for potential new antidepressants relies heavily upon the
uptake inhibitory property of the tricyclics.

Although the

property of uptake inhibition fits the heuristic biogenic
amine hypothesis, it has yet to be established that the
therapeutic effect is mediated by this mechanism either
entirely or in part.
A test of the hypothesis that tricyclic antidepressants
mediate this therapuetic activity by inhibiting the uptake
of biogenic amines can be approached experimentally using
isolated pinched off nerve endings (synaptosomes) as a
model of nerve endings functioning in-situ (Kuhar, 1973;
Bradford, 1975).

Characterization of the model and optimi-

zation of the parameters for unidirectional transport are
the required preliminary experiments.

The classical pharma-

cological approach necessitates establishing a time course
for the effect as well as a dose-response curve.

Treatment

effects may then be compared with that of vehicle injected
controls to conclude the test of this hypothesis.
To confirm that uptake inhibition occurs upon repeated
administration of tricyclics would lend support to the biogenic amine hypothesis and further substantiates the concept
that tricyclics may mediate their effect by virtue of this
well documented property.

5

CHAPTER II:

REVIEW OF THE LITERATURE

6

A.

Neurotransmitter inactivation by uptake processes:
historical background.

An

Interest in measuring the uptake of catecholamines and
the physiological significance of this process came about
as a result of a number of experiments designed to illustrate
the mechanism by which catecholamines are inactivated under
physiological conditions.

Monoamine oxidase (MAO) was then

considered the enzyme responsible for inactivating the
catecholamines at sympathetic nerve endings in much the same
way in which acetylcholinesterase was thought to act at
cholinergic neurons (Burn, 1953).

Koelle and Valk (1954)

reported that unlike acetylcholinesterase in cholinergic
neurons, MAO is not selectively associated with adrenergic
neurons.

Kamijo et al. (1955), Balzer and Holtz (1956) and

Corne and Graham (1957) all reported the inability of a
variety of MAOI's to significantly potentiate the actions of
catecholamines either administered exogenously or released
by stimulation of the sympathetic nerve.
Catechol-0-methyltransferase (COMT ) has been shown to
play a role in the metabolism of catecholamines (Axelrod,
1957, 1959; Hertting and Axelrod, 1961; Rosell et al., 1963),
but Bacq (1959) reported only a slight potentiation of the
effects of endogenous catecholamines produced by stimulation
of sympathetic .nerves after COMT was inhibited by pyrogallol.
Wylie et al.

(1960) reported similar results upon admini-

stration of exogenous catecholamines as did Murnaghan and
Mazurkiewicz (1963) using another COMT inhibitor, 4-methyltropolone.

7
Burn (1932) first suggested that exogenously administered catecholamines might be taken up into storage sited
of certain peripheral tissue, but it was not until fifteen
years later that Raab and Humphreys (1947) reported an
increase in catecholamine content of cat and dog hearts
after the administration of large doses of epinephrine and
norepinephrine.
Acceptance of the importance of tissue uptake in the
inactivation of catecholamines awaited the development of
radioactively labeled catecholamines with high specific
activity and this uptake was demonstrated by Axelrod et al.

(1959).

3H-Epinephrine (O.l mg/kg) administered to mice

was found to disappear in two phases.

The first phase was

a rapid metabolism of approximately 7CJ% of the injected
dose.

The remaining 30%, however, disappeared more slowly.

The interpretation of these results was that exogenously
administered catecholamines are accumulated in tissues and
may serve to inactivate catecholamines under normal physiclogical conditions.

Whitby et al. (1961) drew the same

conclusions from the

res1~lcs

ments.

of similarly designed experi-

Further support for the concept of uptake being

responsible for inactivation of catecholamines came from
Muscholl (1961) using a combination of bioassay and flourimetric techniques and from the laboratory of Stromblad and
Nickerson (1961) as well.

Numerous reports substantiating

this conclusion followed and are reviewed by Iversen (1965).
Considerable evidence has accumulated to suggest that

8

the uptake of catecholamines occurs into post-ganglionic
nerve endings.

Kopin et al. (1964) maintained that if

allowances are made for differences in regional blood flow
through various tissues studied, there is a good correlation between the accumulation of norepinephrine and the
level of endogenous norepinephrine.

The levels of endog-

enous norepinephrine may be taken to reflect the extent of
innervation of the organ or tissue by sympathetic postganglionic terminals, although turnover may be judged a
better indicator by some (Costa, 1969).

Additional evidence

that the uptake of norepinephrine occurs primarily into
sympathetic post-ganlionic neuronal endings became available
when Hertting et al. (1961) reported almost complete disappearance of the ability of norepinephrine and epinephrine
to accumulate in tissues in which the sympathetic postganglionic nerves innervating the tissue had been cut and
the terminals allowed to degenerate.

This approach was

modified by Zaimis et al. (19 65), Iversen et al. (1966) and
Sjoqvist et al. (1967) whereby sympathetic innervation was
obliterated by immunosympathectomy at birth; the results
obtained were similarly interpreted.
A number of techniques have been employed to conclude
that localization of accumulated radiolabeled norepinephrine
occurs predominantly in neuronal endings include studies
using density gradient centrifugation (P otter and Axelrod,
1962; 1963), autoradiography and electron microscopy (Werle
et al., 1962;

~arks

et al., 1962; Samorajski et al., 19 64)
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and histochemical flourescence techniques (Hamberger et al.,
1964).

Although the evidence implicates the neuronal

ending as the site of uptake, methodology at that time was
not available to accurately separate and describe the component of uptake into tissue other than neuronal endings.
Fischer and Kopin (1964), however, did present evidence to
indicate that the uptake of catecholamines was not limited
to neuronal tissue in their report describing uptake into
denervated salivary glands of the rat.
Further elaboration of the characteristics of uptake
systems of peripheral tissues came about as a result of
attempts to study the effects of drugs.

Macmillan (1959)

proposed the "nerve uptake hypothesis" ascribing the potentiating properties of cocaine to its ability to interfere
with the catecholamine uptake mechanism.

Adrenergic

blocking agents were found to inhibit the uptake of 3Hnorepinephrine including phenoxybenzamine and dicholroi soproterenol (Axelrod et al., 1962b).

Tricyclic anti-

depressants, neuroleptics of the phenothiazine class as
well as guenethidine, bretylium and ouabain were shown to be
effective inhibitors of the noradrenergic uptake mechanism
(Axelrod et al., 196lb; Herhitting et al., 1962; Dengler et
al., 1962) as well as the sympathomimetic amines tyramine,
amphetamine and ephedrine (Axelrod and Tomchick, 1960;
Axelrod et al., 196la, Heritting et al., 1962; Dengler et al.
1961).
Muscholl (1960), Axelrod et al. (196lb) and Heritting

10

et al. (1962) all reported that reserpinized tissues failed
to accumulate epinephrine and norepinephrine.
found that the accumulation of epinephrine

Dengler (1961)
and norepin-

ephrine in tissue slices was prevented when reserpine was
present in the incubation medium .

As a result of these

experiments there was relatively wide acceptance that reserpine inhibited the uptake of catecholamines (Brodie and
Beaven , 1963).

After an extensive review of the literature,

however , Shore (1963) concluded that the actions of reserpine were predominantly centered around the intracellular
uptake and storage mechanism and not the neuronal membrane
uptake system.

Direct evidence to support this hypothesis

came from Lindmar and Muscholl (1964) where in both normal
and reserpinized

is~lated

rat heart preparations, they

infused 0.5 ug of norepinephrine over a 10 minute period
and collected and analyzed the perfusate for unchanged
norepinephrine.

Analyzing the norepinephrine content of

the heart after the perfusion interval, they determined that
in normal hearts the catecholamine taken up from the medium
was almost entirely accounted for as unchanged norepinephrine
accU!Ilulated into the tissue .

In reserpinized hearts, how-

ever, the amount of norepinephrine in the perfusate was the
same as in the perfusate of normal hearts, but tissue analysis revealed very much lower levels of catecholamine
very high levels of MAO metabolites in the perfusate .

·;i i

th

These

These results suggested that norepinephrine accumulation was
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not affected but its subsequent storage was.
Iversen (1965a, 1965b) reported characteristics of the
uptake of norepinephrine into isolated rat hearts.

At low

concentrations of epinephrine or norepinephrine (.07 - 7 uM)
the uptake followed classical Michaelis-Menten kinetics and
Km and Vmax values where calculated showing a greater

affinity of the stereoisomer, 1-norepinephrine, for the
uptake mechanism than d-norepinephrine.

The racemate,

dl-norepinephrine, exhibited a higher Vmax and lower Km
than dl-epinephrine.
Similar experiments were performed using high concentrations of catecholamines (5-230 uM) in the perfusion
medium (Iversen 1965a, 1965b).

The accumulation of catech-

olamines under these conditions could not be explained in
terms of the uptake system described when using low catecholamine concentrations in the perfusate, however, the characteristics of this uptake process could be described using
classical enzyme kinetic models.

This second uptake system,

a process for which the term Uptake 2 (u 2 ) has been applied,
showed a much lower affinity than could be ascribed to the
initial uptake system described (referred to as Uptake 1,
abbreviated u1 ).
Several properties of u2 serve to distinguish it from
u1 • Catecholamines accumulated by u2 disappeared rapidly
from the tissue if the perfusion was continued using a
catecholamine-free medium, although 2 ug. of catecholamine
per gram of tissue remained even after prolonged periods of

12

washout.

A comparison of the kinetic constants showed that

unlike u1 , u2 exhibited no stereospecificity; also, although
u2 accumulated norepinephrine more rapidly, epinephrine
exhibited a greater affinity for uptake with the Km being
about five times lower than that for norepinephrine.
Although u2 appeared inoperative at low substrate concentrations and thought to be activated where a critical threshold of substrate concentration is reached (Iversen, 1965a),
a more recent study reported evidence to conclude that both
systems operate at all substrate concentrations with u1
having the greater influence at low and u2 at high substrate
concentrations (Lightman and Iversen, 1969).
Another property serving to distinguish between u1 and
u2 includes substrate specificity and the effect of drugs
on inhibiting the transport effected by each system. Burgen
and Iversen (1965) reported the results of a variety of
substituted B-phenylethylamines on the u2 system. Interestingly, 0-methylation as well as N- substitution greatly
enhanced that affinity for u2 ; whereas the effect of these
compounds on u1 are exactly opposite in nature (Horn, 1973).
Cocaine, imipramine and desipramine while potent inhibitors
of u1 were found to be only weakly active with respect to
u2 (Iversen 1965a; Salt, 1972). Phenoxybenzamine is a
potent inhibitor of u2 as is a variety of steroids including
B-estradiol, corticosterone, testerone, deoxycorticosterone
and androsterone (Iversen and Salt, 1972).
Originally it was suggested that u2 might represent a

13

sepq rate neuronal membrane transport system at sites along
the entire neuron; that is, cell body, axon and nerve
terminal.

Evidence for this concept was provided by the

histochemical studies of Norbert and Hamberger (1964) and
Hamberger et al. (1964) who reported that the accumulation
of norepinephrine was localized to terminal regions of postganglionic sympathetic neurons when low doses of norepinephrine were administered and amine throughout the cell
body and axon as well as the terminals when high doses were
administered.

This hypothesis, however failed to explain

the washout phenomenon reported to exist for

u2 •

Another possibility offered was that u2 may represent
an uptake of catecholamines by storage granules within
adrenergic neuronal terminals (Iversen, 1965a).

Evidence

for this hypothesis included the indisputable similarity of
properties between u2 and eith er isolated adren ergic nerve
granules or adrenal medullary granules incubated in-vitro
(Euler and Lishajko, 1964; Carlsson et al., 19 63).

The

particle uptake system is saturable at amine concentrations
of 80 ug/ml. which is very close to that described for u2 ,
also, both are relatively insensitive to inhibition by
cocaine, desipramine or metraminol and both are inhibited by
tyramine and p k enoxybenzamine.

Granular uptake lacks

specificity for the optical isomers of epinephrine and norepinephrine.

Finally, the uptake of catecholamines in

isolated granules occurs at concentrations of 1 ug/ml. or
higher in the absence of magnesium and adenosine triphos-

14

phate and u2 is known to begin to exert substantial influence
at this concentration of amine. One important difference
between u2 and the isolated particles is reflected by the
fact that no difference in affinity can be shown for
epinephrine and norepinephrine as can be observed in the u2
system.
The hypothesis which has gathered the most support by
far is that

u2

represents an extra-neuronal uptake mechanism

(Iversen, 1975).

Support has come from the results of

histochemical studies of the distribution of catecholamines
in various tissues after exposure to high concentrations
of exogenously administered norepinephrine.

The work of

Fisher and Kopin (1964) cited earlier may have provided
that needed impetus to investigate the association between
non-neuronal or extra-neuronal uptake and u2 • After perfusion of rat hearts with medium containing high concentrations of norepinephrine, intense flourescence was observed
in cardiac muscle cells and unidentified connective tissue
cells as well as nerve terminals (Ehinger and Sporrong,
1968; Farnebo and Maimfors, 1969; Clarke et al., 1969;
Extraneuronal uptake, like u2 ,
was found to be sensitive to normetanephrine and relatively
Jacobowitz and Brus, 1971).

insentive to desimpramine (Farnebo and Malfors, 1969; Clarke
et al., 1969).

Numerous reports of uptake of catecholamines

into nonneuronal tissue including salivary gland parenchyma
(Hamberger, 1967), smooth muscle of cat spleen (Gillespie
1968, 1973), vas deferens (Gillespie et al., 1970), chick
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amnion (Burnstock et al., 1971), perfused rabbit ear artery
(Avakian and Gillespie, 1968), cat nictitating membrane
(Draskoczy and Trendlenburg , 1970) and guinea pig trachea
(O'Donnell and Saar, 1973), appeared.

Kinetic constants for

the extra-neuronal uptake into arterial cells was shown to
have characteristics similar to u2 (Gillespie and Towart,
1973). The uptake of norepinephrine into smooth muscle
also showed susceptibility to phenoxybenzamine and washout
was inhibited by normetanephrine (Gillespie, 1968).
Although

u1

has been considered the principal mechanism

responsible for the inactivation of physiological concentrations of norepinephrine (Iversen, 1971), the preponderance
of sympathetic innervation is clearly a consideration in
determining the importance of either uptake mechanism in
isolated tissue preparations, as is the concentration of
catecholamine in the medium.

Smooth muscle of the vas-

culature contains relatively little sympathetic innervation
and it would seem reasonable to conclude that u2 is most
important in terminating the action of circulating catecholamines in this tissue.

The evidence to support the

hypothesis that neuronal uptake isthe principal inactivating
mechanism of depolarize-released neurotransmitter comes
from reports that organ response to sympathetic nerve stimulation is greatly increased by drugs shown to be effective
inhibitors of the neuronal uptake mechanism (Thoenen, 1964a,
1964b; Brown , 1965).

Based on results reported by Langer

(1970), u1 may account for the recapture of as much as 70-
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90% of the transmitter released by low frequency sympathetic
nerve stimulation in the cat nictitating membrane.
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B.

Characterization of kinetically distinct neuronal uptake
mechanisms.
i) Norepinephrine, dopamine and tyrosine:
Norepinephrine uptake as an active process described

using Michaelis-Menten kinetics was dissociated from the
contribution of passive diffusion by using low substrate
concentrations (l0- 7 M) in the medium of brain slice preparations (Dengler, 1962).

The active component of uptake into

brain slices was shown to be temperature dependent, occur
against a concentration gradient, be dependent upon Na+ in
the medium, require oxygen and glucose, can be lowered by
metabolic inhibitors (Dengler et al., 1962; Dengler, 1965;
Ross and Renyi, 1964, 1966), and does not require calcium
or magnesium ions (Hamberger, 1967).

Limited accumulation

occurs when incubation is carried out in a sucrose medium
(Mirkin et al., 1963).
Similar results have been reported with the use of a
crude _synaptosomal homogenate.

Davis et al. (1967),

Bogdanski and Tissari (1967), Bogdanski et al. (1968)
Colburn et al. (1968) and White and Keen (1971) all showed
an absolute requirement for 143 mM Na+ concentrations and
inhibitory effects of increasing K+ concentrations above
5mM, as well as temperature dependence and reduction in
uptake by metabolic inhibitors.

Conclusions of these

studies suggest that uptake by brain slices, at low substrate concentrations similar to that used by Dengler (1962),
occurs primarily into neuronal endings.
Harris and Baldessarini (1973) showed similar require-
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ments for dopamine uptake into rat corpus striatum with one
notable exception.

Whereas Snyder and Coyle (1969) reported

no substantial effect on initial uptake of catecholamines
using reserpine pretreatment, Harris and Ealdessarini (1973)
reported a considerable effect.
Additional support for the hypothesis that amine accumulation occurs into nerve endings comes from the work of
Snyder et al. (1965) who showed that intraventricular
injection of labeled norepinephrine was found localized to
a great extent in the synaptosomal fraction upon differential centrifugation.

Histochemical techniques confirmed

that the uptake of monoamines into rat cerebral cortex was
confined to varicosities indistinguishable from those containing endogenous norepinephrine (Eamberger and Masuoka,
1965; Hamberger, 1967).

Eenn (1967) using electron microscopic autoradiography reported that 8 0% of the H3-norepinephrine accumulated by brain slices was localized to

neurons.

More recently Lidbrink and Jonsson (1974) showed

a reduction of uptake of norepinephrine into cerebral
cortices after noradrenergic terminals were destroyed by
lesion of the dorsomedial reticular formation with 6-hydroxydopamine.
Snyder and Coyle (1969) studied the stereospecificity
of norepinephrine and dopamine uptake in different areas of
the rat brain.

The Michaelis constant of 0.4 uM for nor-

epinephrine uptake into extrastriatal areas is in good
agreement with the 0.56 uM Km reported by Colburn et al.
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(1968) using whole rat brain.

Snyder and Coyle (1969)

extended the range of catecholamine concentration from 0.05
uM using 1.2 uM as the upper limit.

They reported that the

striatum had a higher affinity for dopamine than norepinephrine and both neurotransmitters display only a single
uptake component over the
studied.

ra.~ge

of substrate concentrations

All other brain areas showed two components of

dopamine uptake, one considered a high affinity the other a
low-affinity transport mechanism, whereas norepinephrine
continued to be described adequately by a straight line
using the Lineweaver-Burk method suggesting only one transport system exists for this amine.

In a later paper (Coyle

and Snyder, 1969), they reported the Ki values for mutual
inhibition of dopamine and norepinephrine uptake in all
regions of rat brain to be identical with their respective
Km values and concluded that these two catecholamines use
the same transport systems (presumably dopaminergic) and
would not require such a characteristic.
The uptake of precursors of norepinephri:ooand dopamine,
namely tyrosine and dopa, have been described (Naeme, 1961;
Guroff et al., 1961; Dengler et al., 1962; Yoshida et al.,
1963a, 1963b, 1963c, 1965) but delineation of two transport
systems has not been the focus of attention and wh eth er
these systems exist remains to be sh own.

Chiri g os et al.,

(1960) have reported stereospecificity of 1-tyrosine for
brain tissue and illustrated its uptake inhibition by the
amino acids leucine, isoleucine, valine, histadine and
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cysteine.

They also noted that stereospecificity was

lacking in muscle preparations.

Interestingly, Ross and

Renyi (1966) studied the uptake of tyramineand 1-dopa at
concentrations similar to those reported for high affinity
uptake of dopamine (Snyder and Coyle, 1969) and reported
Km's for dopamine and tyrosine of 0.7 uM and 0.4 uM,
respectively, in slices of whole brain.

These values are

similar to those reported for extra-striatal norepinephrine
uptake (Coyle and Snyder, 1969; Snyder and Coyle, 1969).

It

would appear that these Km values adequately describe a
high affinity component of uptake when compared with other
amino acids with Km's in the millimolar range (Cohen and
Lajtha, 1972).

In addition, Wofsey et al. (1971) present

evidence to indicate that tyrosine may become selectively
incorporated into a population of synaptosomes that can be
separated from those which accumulate norepinephrine by a
technique known as incomplete equilibrium centrifugation.
ii) Seroton"in and tryptophan:
Fuxe and Ungerstedt (1967) described the localization
of intraventricularly administered serotonin to serotonergic
neurons using histochemical flourescence techniques.
Although a number of attempts were made to illustrate
serotonin accumulation in brain slices (for a review see
Katz and Chase, 1970) most attempts were unsucessful in
separating out an active transport process fro.m simple diffusion until Blackburn et al. (1967) incubated brain slices
with c14 -serotonin at a concentration of 2xl0- 8 M and
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reporte~

considerable accumulation of the amine with 60Yo

recovered in the synaptosomal fraction upon subcellular
fractionation using differential centrifugation techniques.
Similarly, Kuhar et al. (1970) studied the subcellular
localization of serotonin after incubation of brain slices
with the amine in concentrations ranging from 10- 5 to 10- 8 M
and found the major portion of accumulated serotonin localized to synaptosomes.
The kinetics of serotonin accumulation into slices of
rat striatum and hypothalamus revealed two distinct transport processes with KmH=l.7xl0- 7M and Km1 =8 .0xl0- 6M in t h e
striatum and KmH=l.4xlO -7 M and Km1 =8.0xl0 - 6M in the hypothalamus (Shaskan and Snyder, 1970).

The Ki values for t h e

competitive inhibition of norepinephrine uptake by serotonin
approximated the Km for low affinity serotonin into catecholaminergic neurons.

These kinetically distinct components

were confirmed by Wong et al. (1973).
Kuhar et al. (1974) review the results of a number of
studies illustrating the reduction of serotonin uptak e
associated with the selective destruction of serotonin nerve
terminals by midbrain raphe lesions suggesting that uptake
occurs predominantly into serotonergic nerve endings wh en
low substrate concentrations are employed.

Histochemical

flourescence as well as the measurement of tryptophan
hydroxYlase activity and endogenous serotonin levels support
the hypothesis that high affinity uptake process is specific
for neurotransmitter inactivation upon depolarized release
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(Kuhar et al., 1972).

Massari and Sanders-Bush (1975) have

utilized this concept of high-affinity neurotra.nsmitterspecific uptake to compare the effects of para-choloroamphetamine or B-9 lesions with the distribution of serotonergic neuronal endings in different areas of the brain.
Initial studies of tryptophan transport into synaptosomal preparations utilized substrate concentrations limited
to the low affinity component of transport (Grahame-Smith
and Farfitt , 1970).

In this study the concentrations of

sodium ions in the media were varied from 0 to 112 mM by
osmotic replacement with either choline or sucrose and
resulted in no effect on tryptophan uptake, however, cyanide
and ouabain did significantly reduce the uptake of substrate.
Interestingly, preloading the synaptosomes with 1-tryptophan
resulted in an increase in the uptake of either 1-tryptophan
or 1-phenylalanine.
were also

sh o~n

L-Tryptophan preloaded synaptosomes

to greatly accelerate the rate of efflux of

tryptophan by either 1-tryptophan or 1-phenylaJanineimplying
that a faciltated exchange process was occuring.

A number

of amino acids were reported very active in stimulating the
efflux of tryptophan from preloaded synaptosomes.

It would

appear that this low affinity transport system represents
the same mechanism by which other amino acids gain entry
into the neuron and is not specific for tryptophan.
A more recent study revealed a high affinity component
of the uptake of 1-tryptophan as well as a low affinity
component (Parfitt and Grahame-Smith, 1974).

Alth ough the
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affinity Michaelis constant (KmL) originally reported by
Grahame and Parfitt (1970) as l.Oxl0- 3M is considerably
disparate from their more recent data ( KmL 3.2xl0- 4M); use
of different tissue preparation, i.e. whole brain vs.
cerebral cortex, can account for the results.

The KmH,

however, is only lower than the the KmL by a factor of
three reported in this study, (Parfitt & Grahme-Smith, 1974),
whereas, other investigators have reported differences
between high and low affinity uptake systems differing from
a minimum of 21 (in cerebral cortex) to over 300 (glycine in
the spinal cord) orders of magnitude which would appear to
represent physiologically more distinguishable processes
(Snyder et al., 1973).
iii) Other neurohumors:
a) Acetylcholine and choline:
Unlike the catecholamines and serotonin, acetylcholine
appears to be inactivated largely by the intrasynaptic
degradative enzyme acetylcholinesterase and diffusion rat h er
than an uptake mechanism (for a review see Katz and .1iledi,
1

1973).

Early work aimed at characterizing an uptake process

for acetylcholine did not prove fruitful (Guth, 1962;
Burton, 1964).

Even in the presence of the reversible chol-

inesterase inhibitor physostigmine, negative results were
reported (Elliot and Henderson, 1951; Schuberth and Sundwall,
1967) although it was suggested that physostigmine may have
strong inhibitory actions on the uptake mechanisms (Polak
and Meeuws, 1966).

Use of the organophosphate cholinester-.
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ase inhibitors including paraoxon (Diethyl-4-nitrophenyl
phosphate) have resulted in significant accumulations of
acetylcholine into brain tissue (Polak and Meeuws, 1966;
Schuberth and Sundwall, 1967; Liang and Quastel 1969;
Heilbronn, 1969) with the uptake requirement for oxygen,
reduced by metabolic inhibitors and described using
Michaelis-Menten kinetics (Schuberth and Sundwall, 1967;
Polak and Meeuws, 1966; Liang and Quastel, 1969).
Acetylcholine uptake seems unimportant physiologically
for it has been shown that acetylcholine uptake into synaptosomes is neither readily incorporated into vesicles
( Marchbanks, 1968) nor released by electrical stimulation or
potassium depolarization (Katz et al., 1973).

Further

evidence leading to a conclusion that acetylcholine uptake
is not physiologically important comes from the results of
Marchbanks (1969b) and Adamic (1970) suggesting that both
molecules utilize the same carrier.

Similarly autoradio-

graphic techniques have been employed using slices of rat
cortex incubated in labeled acetylcholine and the distribution of label

w~s

reported as diffuse with no obvious

preference for specific cell types or structures (Polak,
1969).

Finally, Katz et al. (1973) attempted to collect t h e

excess acetylcholine which might be produced by brain
stimulation in the presence of an acetylch oline uptake
inhibitor if the acetylcholine transport
iologically active.

process were phys-

They report that no additional acetyl-

choline is collected in the presence of uptake inhibitor
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and conclude that acetylcholine uptake may not be physiologically operational.

These results may be explained by

considering the transport mechanism responsible for acetylcholine uptake to be identical with the choline carrier;
the low affinity choline transport mechanism being common
to all cells requiring choline as substrate for synthesis
of phasphatidyl- or phosphorycholine.
Hodgkin and Martin (1965) first described the ability
of choline to be transported into excitable .tissue, the
squid axon.

A year later Schuberth et al. (1966) reported

the presence of choline in cerebral cortex tissue slices
and localization of choline transport within nerve endings
was established by Marchbanks (1968b) using synaptosomal
preparations with a reported Km of lOOuM.

A number of

similar studies reported Km's varying from as low as 80 uM
(Potter, 1968) to 440 uM (Hensworth and Bosmann, 1971).
Green and Haubrich (1971) using synaptosomal preparations incubated with low concentrations of choline, reported
a significant amount of acetylcholine formed and suggested
that more than one uptake system may exist for choline
accumulation in the brain.

Yamamura and Snyder (1973) and

Dowdall and Simon (1973) reported two kinetically distinct
carrier-mediated systems for choline transport having a
of 1-5 uM and KmL less than 25 uM.

K~

The two systems showed

clearly distinguishable effects of Na concentration (Haga
and Noda, 1973) with the high affinity component more dependent on alterations in sodium concentration in the media.
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Although it has been suggested that the high affinity
component represents a mechanism of cholinergic neurons
which may serve to recapture the product of intrasynaptic
acetylcholinesterase for the synthesis, storage and subsequent reutilization of acetylcholine, conclusive evidence
of this is not available as yet (Kuhar and Murrin, 1978).
Kuhar , et al. (1973) have provided evidence to indicate
that choline uptake occurs into cholinergic neurons primarily by the high affinity uptake process.

Septal lesions,

known to result in reductions of acetylcholine in the
cerebral cortex and hippocampus, resulted in a reduction of
choline uptake by 6alo in synaptosomes prepared from these
cholinergically innervated areas, whereas, tryptophan and
glutamatic acid accumulation were unaffected although GABA
and norepinephrine uptake were affected slightly.
b) gamma-Aminobutyric acid (GABA)
GABA was shown to be taken up by slices of rat cerebral
cortices when a low concentration (0.05uM) of substrate was
used in the medium (Iversen and Neal , 1963).

The electron

microscopic autoradiographic experiments of Bloom and
Iversen (1971) suggest that more than

7cY~

of the GABA

taken up into brain slices is localized to the nerve terminals.

It has also been suggested that at this low concen-

tration, reminiscent of that used to detect high affinity
uptake, a distinct population of nerve terminals are responsible for the uptake of labeled GABA (Iversen and Snyder,
1968; Iversen and Johnston, 1971).

Clearly distinguishable
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high and low affinity components for GABA uptake into
synaptosomes and brain slices have been reported (Levi and
Raiteri, 1973a, 1973b).
As with other high affinity transport systems there is
an absolute requirement for physiological concentrations of
electrolytes and uptake is inhibited strongly by low concentrations of Na+ (Iversen and Neal, 1968).

Inhibition of

GABA uptake has been reported with 2,4-dinitrophenol, ouabain and malonate (Kuriyama et al., 1969; Snodgrass et al.,
1973).
c) Glutamate, aspartate and glycine:
Logan and Snyder (1972), Balcar and Johnston (1972a,
1972b) and Bennett et al. (1972) have studied the uptake of
glutamate and aspartate and have reported that transport
occurs by both high and low affinity mechanisms with the
high affinity system having an absolute dependence on
sodium ions.

Furthermore, the metabolic requirements of

both glutamate and aspartate uptake are indistinguishable
with azide, eyanide and omission of glucose from the media
having minimal effects and it appears as though glutamate
and aspartate share the same transport carrier.

Wofsey

et al. (1971), using subcellular distribution studies, have
associated the high affinity uptake with a unique population of nerve terminals suggesting that the high affinity
mechanism may be directly related to the function of
replenishment of neurotransmitter.
A high affinity uptake system specific for glycine has
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been shown in slices of rat spinal cord, pons and medulla
( Neal, 1971; Jolmston and Iversen, 1971), slices of cat
spinal cord (Balcar and Johnston, 1973) as well as in crude
synaptosomes of rat spinal cord (Logan and Snyder, 1972;
Bennett et al., 1972) and in purified synaptosomes of
cerebral cortex of the rat (Peterson and Raghupathy, 1973).
Localization of glycine uptake into nerve endings by the
high affinity system has been shown by autoradiographic
analysis

( ~atus

and Dennison, 1972; Iversen and Bloom, 1972;

Ehinger, 1972; Hosli and Hosli, 1972; Ljungadhl and Hokfelt,
1973) as well as subcellular fractionation teclmiques
(Johnston and Iversen, 1971; Arregui et al., 1972).
Glick (1972) has shown inhibitors of Na+/K+ dependent
ATP-ase to be effective inhibitors of glycine uptake; however, no inhibitors has yet been described as being more
effective in inhibiting either the high or the low affinity
uptake.

The low affinity mechanism of glycine uptake seems

to be relatively

no~-specific

and other small neutral

a,~ino

in that 1-alanine,l-serine
acids compete for the trans-

port site (Cohen and Lajtha, 1972).
d) Histamine and histadine:
Although the probable mechanism of histamine inactivation is via the degradative enzyme histamine methyltransferase, subcellular distribution studies show the incorporation into the P 2 (synaptosomal) fractions and after subsequent treatment in a hypo-osmotic medium histamine was
shown to be localized to the vesic11lar fraction (Snyder

2~

et al., 1974).

Young et al. (1971) reported an ontogenic

related change in the distribution of histamine among subcellular fractions.

Older animals (21 days) showed greatest

accumulation in the synaptosomal fraction whereas younger
animals appeared to concentrate histamine in the nuclear
pellet.
A

stereospecific uptake of L-histidine into brain slices

has been demonstrated ( Neame, 1964) although the substrate
concentrations were not low enough to differentiate a high
affinity component and in all probability the low affinity
system is shared by other basic amino acids such as tryptophan.
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c.

Effects of tricyclic antidepressants on the hi-affinity
uptake process of serotonergic noradrenergic and
dopaminergic neurons.
i) in-vitro
The ability of tricyclic antidepressants to block the

uptake of norepinephrine into brain slices was described
by Dengler et al. (1961) using concentrations of radioactively labeled norepinephrine (2.8 - 14.0xl0-8 M) well
within the concentration range where hi-affinity transport
is responsible for a large part of the uptake of
ephrine into nerve endings.

nor~pin

The concentration at which the

uptake of norepinephrine into nerve endings is inhibited by
fifty percent,

(rc 50 ),

varies depending upon the prepara-

tion used, i.e. brain slices versus synaptosomes, as well
as by brain region.

The

rc 50

for desmethylimipramine (DMI)

varies from 0.003 uM in rat brain synaptosomes (Ross and
Renyi, 1975a) to 0.11 uM in rat brain slices (Salama et al.,
Buus Lassen et al., (1975) reported an 1c 50 for DMI
of 10 uM in rat forebrain synaptosomes as opposed to 0.001

1971).

uM in synaptosomes prepared from rat hippocampal tissue.
The large difference is believed to be due to the concentration of noradrenergic neuronal endings within brain regions
(Squires, 1974; Buus Lassen et al., 1975).
It is also true that studies utilizing different species

rc 50

as well as different preparations reported identical
values for the tricyclics tested.

Ross and Renyi

(1967a) utilizing mouse cortex slices reported an 1c 50
value of 0.03 uM for the inhibition of norepinephrine uptake
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by DNI whereas an identical value was reported by Shaskan
and Snyder (1970) using a crude synaptosomal homogenate of
rat hypothalamus.

A good correlation between the partition

coefficient and the Ic

values for a number of chemically
50
different uptake inhibitors was found to exist in brain
slices (Carmichael and Israel, 1973).
All studies report DMI to be the most potent tricyclic
tested with respect to its ability to block norepinephrine
uptake (Ross and Renyi, 1967a; Shaskan and Snyder, 1970;
Horn et al., 1971; Salama et al., 1971; Carmichael and
Israel, 1973; Squires, 1974; Maxwell et al., 1974; Ross and
Renyi, 1975a; Buus Lassen et al., 1975).

Many studies

indicate that the demethylated form of the tertiary amines,
i.e. the secondary amines, are more potent with respect to
their ability to inhibit norepinephrine uptake whereas the
tertiary amines are more efficacious in its effect on serotonin uptake (Blackburn et al., 1967; Ross and Renyi 1967b;
1969; Carlsson, 1970; Shaskan and Snyder, 1970;
Kannengiesser et al., 1973; Horn and Trace, 1974; Ross and
Renyi, 1975a and Buus and Lassen et al., 1975).
Structure activity relationships have been studied
with respect to both the noradrenergic ( Horn and Snyder,
1972; Ferris et al., 1972; Horn, 1973a; Maxwell et al.,
1974) and serotonergic ( Horn, 1973b) transport system in the
central nervous system.

It is on the basis of these studies

that evidence can be found to substantiate the concept that
there exists a chemically distinguishable transport
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mechanism for each neurotransmitter.
The uptake inhibitory characteristics of tricyclics as
they apply to dopamine have been studied (Ross and Renyi,
1967a).

Their effect on this transport system has not

generally been considered as important due to the relatively
large

1c 50

values reported (Horn et al., 1971).

There is

no correlation with the inhibition of uptake of dopamine
into either rat hypothalamus or whole brain synaptosomes
with respect to methyl substitution on the side chain nitrogen of any of the tricyclic antidepressants ( Horn et al.,
1971; Halaris et al., 1975).

Alternatively, antiparkin-

sonian drugs have been shown to be very potent in their
ability to block dopamine uptake in the central nervous
system (Coyle and Snyder, 1969b).
ii) in-vivo
Imipramine was shown to reduce the amount of labeled
epinephrine found in homogenates of whole mice when compared
with saline treated controls (Axelrod and Tomchick, 1959).
Similarly, imipramine increased the rate of disappearance of
labeled norepinephrine in the whole animal (Axelrod and
Tomchick, 1960). Hertting et al. (1961) reported reduced
levels of H3-norepinephrine in heart, spleen, adrenals,
liver and muscles with elevated normetanephrine found in
muscle tissue after treatment with imipramine.

Glowinski

and Axelrod (1964) administered imipramine DMI or amitriptyline to rats and after 1 hour administered H3-norepinephrine
by an intra-cerebroventricular (ICV) injection.

All three
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compounds were reported to be effective in inhibiting the
uptake of H3-NE into rat brain. It is interesting to note
that Schanberg (1963) could not show imipramine to be
effective in inhibiting the uptake of 5-hydroxytrptophan,
the precursor of serotonin, into brain slices when the drug
was administered i.p. 1 hour prior to sacrifice with subsequent testing in-vitro.
As with the in-vitro data, many studies measuring the
effectiveness of tricyclics on either norepinephrine or
serotonin uptake report tertiary amines as being more
effective then the secondary amines in blocking the uptake
of 5HT in the central nervous system (Ross and Renyi, 1975b).
Conversely, a number of studies conclude the secondary
amines to be more effective than tertiary amines in blocking
NE uptake (Ross and Renyi, 1967; Schildkraut et al., 1969a;
Carlsson et al., . 1969b; Ross and Renyi, 1975b).
Palaic et al., (1967) reported no uptake inhibitory
effect of DMI lOmg/kg; injected i.p. 20 minutes prior to ICV
H3-5-HT injection. Similarly, Carlsson (1970) could not show
an effect of DMI on the release of serotonin by H75/12 into
rat brain.

Schubert et al., (1970) failed to demonstrate
an effect on the rate of disappearance of H3-5-HT after
intravenous injection of H3 -tryptophan of either secondary
amine, DMI or nortriptyline, whereas both imipramine and
amitriptyline retarded the rate of disappearance of H3-5-HT.

Histochemical evidence is available to suggest that imipramine blocks serotonin uptake (Carlsson et al., 1968;
Corrodi and Fuxe, 1968).
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D. Effects of tricyclics on t he metabolism of biogenic
amines:
i) Serotonin
Da Prada and Pletscher (1966) reported a significant
reduction in the levels of 5-hydroxyindoleacetic acid,
(5-HIAA) the major metaboliteof serotonin in the CNS, for
both imipramine and amitriptyline.

The ratio of product to

precursor indicates that imipramine is slightly more efficacious in reducing the turnover of serotonin and this is
reflected in the in-vitro data as well (Ross and Renyi,
1969; 1975; Kannengiesser, 1973).

Palaic et al., (1967),
using an intracerebroventricular perfusion of H3-5HT at
55 uM concentration for 1 hour, demonstrated a reduction in
endogenous levels of 5-HIAA but not of H3-5EIAA. At this
concentration the predominant idoleamine inactivation
mechanism is presumably a low affinity transport system.
It seems possible that the effect of DMI on inhibiting the
uptake of 5HT may have been overshadowed by the low affinity
transport mechanism as well as diffusion.

A reduction in

endogenous levels of 5HIAA imply decreased activity of the
neuron which may come about as a result of feedback mechanisms in the event DMI is inhibiting 5HT uptake.

Sub-

sequently increases in the intrasynaptic amine concentration
and hence its interaction with post-synaptic receptors is
the postulated mechanism for feedback inhibition (Costa and
Meek, 1974).
c1 4-serotonin was administered intracisternally 15
minutes prior to an i.p. injection of either DMI or I MI
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(25mg/kg) and 2 hours after the intracisternal injection
brains were assayed for H3-5HT and deaminated metabolites
(Schildkraut et al., 1969b).

The results indicate imipr-

amine as being more effective in increasing levels of
radioactive amine.

These results are consistentwith the

idea that the tricyclics reduce the turnover of '5HT by the
postulated inhibitory feedback mechanism.

Similar results

were obtained in the study of Schubert et al., (1970) in
which both imipramine and amitriptyline reduced the turnover of 5HT as measured by a reduction in the ratio of H3tryptophan to H3 -5HT .

Bruinvels (1972) and Alpers and

Himwich (1972) reported reduced turnover of 5HT as a result
of tricyclic treatment.

More recently, Leonard and Kafoe

(1976) showed a decreased turnover of serotonin with both
acute and chronic imipramine as well as DMI treatments.
Buus Lassen et al., (1975) tested the effects of tricyclics
administered 3 hours prior to sacrifice and all resulted in
lowering levels of 5HIAA.
ii) Norepinephrine
Schanberg et al., (1967) administered either I MI or
DMI 90 minutes prior to the intraventricular administration
of H3- NE and demonstrated increased levels of H3-normetanephrine in the brains of drug treated rats.

When the

drugs were given 90 minutes after the intraventricular
injection of H3-NE and animals were sacrificed 3 hours
after the antidepressant, the levels of labeled norepinephrine increased. Norrnetanephrine increased and deaminated
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catechol metabolites decreased reflecting the anticipated
response of agents which block the uptake mechanism.
Schildkraut et al. (1969a) demonstrated greater decreases
in levels of H3-NE by treatment with secondary amines DMI
and PRO than by the tertiary amines I MI and AMI.

In fact

AMI did not result in altering the levels of H3-NE found in
the brains of drug treated rats when compared with saline
treated controls.

These results are similarly reflected in

the in-vitro data of Ross and Renyi (1967a) and Shaskan and
Snyder (1970).

Schildkraut et al. studied the effects of

chronic administration of the tertiary amine, imipramine
(1970), and the secondary amine protriptyline (1971), on the
levels of norepinephrine and its metabolites.

In these

experiments, tricyclic antidepressants were administered
by intra-peritoneal injection and H3 -NE followed 6 hours
later by intracisternal injection.

The animals were sacri-

ficed either 6 minutes or 3 1/2 hours after the labeled
compound was administered.

Upon acute administration,

imipramine significantly reduced the levels of H3-NE when
animals were sacrificed 6 minutes after the label whereas
the reduction by protriptyline was not statistically significant.

Normetanephrine levels were increased whereas

deaminated catechols and 0-methylated deaminated metabolites
were decreased for both drugs studied.

When the animals

were sacrificed 3 1/2 hours after the label was administered,
a trend towards increased values of norepinephrine was noted
but did not achieve statistical significance.

These
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results could be explained within the framework of the
proposed mechanism of action of these drugs as transport
inhibitors.

It seems reasonable that after 9 1/2 hours

the drug was nearly completely metabolized and the neurons
responded to the effect of decreased levels in the presence
of drug to increasing their levels by facilitating the
uptake of amines.

Normetanephrine levels remained somewhat

elevated and deaminated catechol metabolites were not nearly
as depressed as after the 6 minute sacrifice period.

Chronic

administration of either drug resulted in decreased levels
of H3-norepinephrine when studied either 6 minutes or 3 1/2
hours after administration of the labeled amine.

Similarly,

normetanephrine was increased and deaminated catechol metabolites were severelydepressed.

The levels of endogenous

amines were reduced below control f or both drugs.

The data

suggests that both the secondary and tertiary amines have
the same effect on norepinephrine metabolism when administered chronically; that of inhibiting uptake and increasing
turnover as measured by the rate of disappearance of H3- NE
from the brain (levels of H3- NE at 6 minutes vs. levels at
3 1/2 hours after label).

In a more recent study of the effect of chronic administration of DU and Dl\1I, turnover of the biogenic amines
including norepinephrine was reported as being decreased
although the decrease was not statistically significant
(Leonard and Kafoe, 1976).

In these experiments turnover

was measured as the ratio of specific activity of labeled
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product to labeled precursor after administration of H3tyrosine and H3-tryptophan.

The results are obviously at

variance with that reported by Schildkraut et al. (1970,
1971) with respect to the turnover of norepinephrine, and
the authors could not offer a reason for the apparant
discrepancy.

The effects of chronic administration of

tricyclics on the turnover of norepinephrine awaits further
study before a conclusion can be drawn.
iii) Dopamine
Dopamine has been the least studied of the catecholamines with respect to the effects of tricyclic antidepressants on its metabolism.

Da Prada and Pletscher (1966)

reported a slight but insignificant decrease of homovanillic
acid (HVA) after an acute administration of imipramine
whereas amitriptyline caused a significant increase in HVA.
Similar results were obtained by Nielsen (1975) in a study
of the affect of acutely administered amitriptyline.

Levels

of dopamine were shown to be increased although the increase
did not achieve statistical significance.

DMI, however,

did increase the levels of dopamine significantly.
Chronic administration of both imipramine and DMI
decreased the turnover of dopamine (Leonard and Kafoe, 1976).
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CHAPTER III:

EXPERIMENTAL WORK
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A. Introduction:
The use of any experimental system necessitates an
evaluation of its performance characteristics or· characterization.

The rigor applied to characterization is often

goverened by the investigators lrn.owledge and understanding
of the system as acquired through a review of the literature
and personal experience.

In this regard, the following

characterization experiments were performed to establish
some of the important parameters pertinent to the experimental protocol as well as some characteristics believed to
be indicative of a properly functioning system.
Following the characterization are experiments designed
to directly test the hypothesis that protriptyline blocks
the uptake of tritiated 1-norepinephrine in an in-vitro
hypothalamic synaptosomal test after acute, subacute and
chronic administration of the drug.

Since the methodology

employed in the characterization differs little with that
used for the test of the hypot h eses, the methods section
contains a "general methods" section and the deviations
from the general methods are noted in the subsequent numbered subsections corresponding to each individual experiment.
Subsection i through ix can be considered characterization experiments and x through xii are specifically
directed towards the objective of this thesis.
B. Methods:
General:

Male Long Evans rats (Charles River Breeding
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Labs) weighing 200-450 gms. were group housed with food and
water given ad libitum in a windowless room in which an
artificial photoperiod was provided (light: 0800-1600
E.S.T.).

Animals were sacrificed by decapitation at approx-

imately the same time each day (11:00-12:00 noon) to eliminate the possible source of error attributable to chronobiological variations in the uptake of neurotransmitters as
reported by Lew and Quay (1974).

The latency from decapi-

tation to immersion of the dissected brain tissue into ice
cold 0.32M sucrose never exceeded 1.0 minute and was usually
accomplished within 45 seconds.
Brains were dissected using a modification of the
method developed by Glowinski and Iversen (1966).

The

brain was removed from the skull and placed with its ventral
side upon a previously cooled glass plate positioned on ice
(generally within 20 seconds from decapitation).

An ice-

cold stainless steel spatula was used to make a medialsaggi tal incision to the level of the corpus callosum.

With

the lateral ventricles as the starting point the cerebral
cortex was rolled back laterally to expose the hemisphere
of tissue containing the characteristic striae of the
striatum.

The medial aspect of the striatal tissue was

teased free with the blade of the spatula.

After removal of

both striatal tissue masses the cortex was folded closed
and placed on its dorsal surface.

The end of a curved

spatula was inserted at the posterior portion of the Circle
of Willis and maneuvered in such a way as to emerge at its
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anterior portion.

The tissue was dissected free along the

side edges of the spatula with a dissecting needle.

Al-

though ref erred to here as hypothalamic this tissue mass is
predominantly hypothalamic in origin with some mid-brain
tissue as depicted in the diagram provided by Glowinski and
Iversen (1966).

The remaining tissue was placed on either

lateral side and the hemisphere partially separated to
observe the approximate location of the genu of the corpus
callosum.

The brain was then sliced in a coronal plane with

the genu as its posterior boundary.

This tissue mass was

termed forebrain and contained cerebral cortex and some
limbic structures.
The dissected tissue was immediately placed into icecold 0.32 sucrose (l()}b w/v) and allowed to sit on ice until
all dissections were completed.

The tissue was then homo-

genized in a TeflonR -glass tissue grinder with a clearance
of 0.030 cm using 10 up and down strokes at about 1,000
r.p.m.

The supernatant fraction of a 1,000 x g x 10 minute

centrifugation carried out at 4°c in a Sorvall RC-2B
refrigerated centrifuge was used as the crude synaptosomal
homogenate (CSR).
The incubation medium (IM) originally used in preliminary experiments was Kreb's bicarbonate (Umbreit et al.,
1964), as modified by Snyder and Coyle (1969) and contained
in millimoles (mM): NaCl (118.5), KCl (4.8) Cac1 2 (1.2)

KH 2Po

(1.2) MgS0 7H 2 0 (1.2), NaHC0 (24.8), d-glucose
4
3
4
(11.1), ascorbic acid (1.1), disodium ethylenediamine tetra-
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acetic acid (EDTA) (0.13) and the monoamine oxidase inhibitor (MAOI), nialamide (0.01).

The ascorbic acid and EDTA

were added to increase the stability of the neurotransmitters by preventing auto-oxidation shown to occur in
oxygenated media (Iversen, 1972).
One milliliter (ml.) of CSH was introduced into 6-8 ml.
of incubation medium (IM) resulting in a concentration of
0.4 to 0.9 mg. protein per ml. IM.

Protein was determined

by the method of Lowry et al. (1951).

Usually, six aliquots

were equally divided among o0 c and 37°C conditions.

In

some experiments the number of replicates per condition
reached 8.
The radio-labeled neurotransmitter (2uCi/ml) was added
to the I M in a volume of 5 microliters (ul.) per ml. of I M
resulting in an I M which was 0.1 uM with respect to neurotransmitter.

One ml. aliquots (minimum of 3 and maximum

of 8 determinations per condition) were incubated at 37°c
in a Dubnoff metabolic shaker (with no agitation) and an
equal number were kept on ice in glass test tubes (10 mm
O.D. x 75 mm).

After incubation for the specified time

interval (norepinephrine and dopamine, 10 minutes; serotonin
5 minutes) the tubes were placed into a Sorvall RC-2B refrigerated centrifuge to spin at 13,000 x g x 60 minutes to
form a pellet containing synaptosomes, mitochondria and
microsomes or the P 2 fraction described by Gray and
Whittaker (1962).
One-tenth ml. of the supernatant was placed into
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scintillation vials containing 2 ml. of absolute ethanol
prior to the addition of toluene phosphor scintillation
fluid.

Pellets were solubilized in 1.0 ml. of absolute

etha.~ol

with the aid of a bent dissecting needle used to

break up the pellet and the solution was poured into a
scintillation vial.

The tubes were washed with 1.0 ml.

of absolute ethanol and this wash was added to the scintillation vial prior to the addition of scintillation fluid.
Ten ml. of toluene phosphor containing 5.5 g/liter of
2,5-diphenyloxazole (PPO) and 125 mg/liter of B-bis-(2phenyloxazole)-benzene (POPOP) in toluene.

The radioactiv-

ity was counted in a Packard Tri-Carb Model 3335 for 10
minutes.

The efficiency for tritium was optimum (45%) at

a gain setting of 57.5 with the window virtually wide open.
Quenching between samples was not found to be significant
and therefore no correction was made.

Background counts

was subtracted from all samples with counts less than ten
times the value obtained for background.
The data are expressed as either Tissue (or Particulate): Medium ratios or uptake in nanograms/mg. protein/10
minutes (or 5 minutes where applicable).

In preliminary

experiments calculations were performed with the aid of a
computer.

Two programs were used the more complex of which

is presented in the appendix, Figure A-1 is a flowchart and
table A-1 is the program listing.

The less complicated

program was a modification of VIVO to allow for a single
value of protein concentration per neurotransmitter (or

45
brain region) condition.
Mean values obtained by incubating at 0-4°C were
routinely subtracted from values obtained at 37°c as a
control for non-specific adsorption of neurotransaitter to
a variety of binding sites including plasma proteins and
presumably the transport carrier itself.

Uptake was not

found to be saturable at 0-4°C over the concentration range
0.04-2.0 uM.

An untreated sample was used as a value

representing maximal uptake with which drug treated samples
were compared.

Hypothalamic homogenate was used for nor-

epinephrine uptake studies striatal for dopamine and forebrain for serotonin.
i) Determination of neurotransmitter integrity:
The radioactive neurotransmitters used in this study
were obtained from New England Nuclear Co. as H3-l-norepinephrine (H 3-l-NE: 5.85 Ci/mM), 5-hydroxytryptamine
binoxalate (H 3-5-HT: 2.2 Ci/mM), and dopamine ( DA: 1.0 Ci/
mM).

The corresponding unlabeled compounds were obtained

from Sigma Chemical Company as well as the 0-methylated and
deaminated metabolites of the neurotransmitters.

The

unlabeled compounds were spotted on cellulose NM300 thin
layer chromatographic plates in 10 ul. volumes containing
1-5 ugms. of t h e test substance as origi n ally described by
Giese et al. (1967).

Th e plates were allowed to dry after

spotting and were equilibrated i n a TLC t ank f or 30- 60
minutes prior to i mmersion into t h e solvent (butanol: 5N
acetic acid=l00:35).

The solvent travel was spotted after
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approximately 15 cm.

Clear separation of all the neuro-

transmitter was obtained and a test system for neurotransmitter integrity was established by spotting the labeled
neurotransmitter.

After developing, the visualizable spot

was scraped off and placed into a scintillation vial and
counted.

All adsorbent below the spot was placed into a

scintillation vial as was all adsorbent after the spot.
High counts found only directly on the visualized spot were
interpreted to mean the neurotransmitter remained intact.
Once radioactivity either before or after the visualized
spot was apparent, the labeled neurotransmitter was no
longer used.
ii) Time course for incubation
All samples incubated at 37°C were placed in the hot
water bath and removed sequentially over the time intervals
reported in the results.

Another set of tubes identically

prepared except that the labeled neurotransmitter was
omitted, were placed in an ice-water bath.

The labeled

neurotransmitter was added at various times during the
course of the total incubation time beginning with longest
time interval sample (prepared just prior to introducing
the 37°C

samples into the heated water bath).

All tubes

were vortexed after addition of the labeled neurotransmitter.

Results are expressed as Tissue: Medium ratio
calculated as ngms H3 -l-NE gm-l brain:ngms. H3 -l-NE ml.-l
supernatant.

This experiment was repeated 6 times with the

brains of 2-6 animals pooled in different experiments.
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iii) Synaptosomal concentration versus uutake
The synaptosomal concentration was varied by delivering
different amounts of the CSH to the IM and adjusting to an
identical final sucrose concentration in each tube by the
addition of an appropriate volume of 0.32M sucrose.

The

tubes were kept in an ice-water bath until the start of the
experiment at which time half were transferred to the hot
water bath for the previously specifie_d periods of time.
The brains of two to

six animals were pooled for each

experiment and the experiment was repeated five times.

The

results are expressed as a Tissue (Particulate): Medium
ratio calculated ngms. H3 -l-NE/gm brain wet weight: ngms
H3-l-NE/ml and supernatant in an attempt to demonstrate the
concentrative property of the synaptosomal preparation.
iv) Effect of calcium ions and ethylenediamine-tetraacetic acid

An attempt to evaluate the contribution of facilitated
exchange diffusion in the synaptosomal preparation was made
by varying the calcium concentration in the media and
employing ethylenediamine tetra-acetic acid (EDTA) to
ate endogenous calcium.
both 0 and 37°C.

chel~

Six determinations were made at

The mean of the six

o0 c

samples was sub-

tracted from each of the 37°c values followed by the transformation to uptake expressed as ngms H3-l-NE/mg ptotein/
10 minutes.

The media of Coyle and Snyder (1969) was used

as a control to which greater or lesser concentrations of
calcium were compared.
The brains of six aminals were pooled and aliquots
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were placed in media that was identical to the media of
Snyder and Coyle (1969) except that calcium and EDTA were
modified as follows.

For the first condition, l.2mM cal-

cium was replaced with lOmM ca++ and EDTA was omitted.

The

calcium concentration was then lowered to 2.5mM in the
second condition.

The third condition employed was that of

Snyder and Coyle (1969) as a control.

In the fourt h tube

the medium was modified by deleting calcium and adding 0.1
mM EDTA.

The EDTA concentrations were increased logarith-

mically in subsequent tubes to 1.0 and lOmM.

The pH was

checked in each and found to require adjustment in the 10
mM EDTA solution by the drop-wise addition of O.lN NaOH to
bring the pH from 6.6 to 7.4.

All other solutions were in

the range 7.35-7.45.
v) Kinetics
Preliminary studies of the kinetics for the transport
of biogenic amines into the CSH included all three neurotransmitters, 1-norepinephrine, serotonin and dopamine.
Seven substrate concentrations used during preliminary
investigations ranged from 2.0 to 0.01 uM (2-lOuCi/ml.).

An aliquot of the supernatant was used as a measure of the
total radioactivity in the media since the difference
between I M and supernatant counts did not differ by more
than 7% at any time.

The brains of 2 animals were pooled

and the media of Coyle and Snyder (1969) was used in the
studies using serotonin and dopamine as substrate.
1-Norepinephrine kinetics was performed with a calcium-
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free media supplemented with 0.1 uM EDTA.

The substrate

concentrations ranged from 2.0 to 0.01 uM (2-10 uCi/ml.).
Three determinations were made for each condition and the
data was transformed to uptake expressed in ngms H3 -l-NE/
mg protein/10 minutes.

The experiment was repeated three

times.
vi) Subcellular distribution of H3 -l-norepinephrine
Continuous sucrose gradients were prepared using a
Beclanan Density Gradient former resulting in a linear
gradient from 0.38 to l.4M sucrose in a 12 ml. volume.

The

gradients were prepared 3 hours prior to their use and
stored in an ice-water bath until ready for use.

The CSH

was prepared as an outlined above and after incubation and
subsequent centrifugation the pellet was resuspended in a
1.0 ml. volume and layered onto the sucrose gradients.

An identical aliquot of the CSR was prepared in media
in which the monoamine oxidase inhibitor, nialamide, was
omitted.

Unlabeled 1-NE was added to a final concentration

of 0.1 uM and processed in an identical manner as the radioactive sample.
The gradients were centrifuged for 90 minutes at
130,000 x g in an International ultracentrifug e using a
swinging bucket rotor.

Fractions were obtained by piercing

the bottom of polyallomar centrifuge tubes and collecting
·0.4 ml. fractions.
The samples containing radioactive neurotransmitter
was assayed for tritium by placing 0.1 ml. samples into
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scintillation vials containing 2 ml. of absolute ethanol to
which 10 ml. of toluene phosphor was subsequently added.
Unlabeled neurotransmitter samples were assayed for
monoamine oxidase activity by a modification of the method
of Wurtman and Axelrod (1963).

A 0.1 ml. aliquot of the

sample was added to 0.25 ml. of phosphate buffer (pH 7.4)
in a test tube. c 14 -tryptamine was added and the tubes
were incubated at 37°c for twenty minutes.

The reaction

was stopped by the addition of 0.2 ml of 2N HCI and the
indole acetic acid formed was extracted into 6 ml. of
toluene by shaking.

Four ml. aliquots of the toluene were

placed into scintillation vials and 10 ml. of toluene
phosphor added prior to counting.

The results obtained are

expressed as percent of radioactivity in each fraction compared with the sum of all fractions.
vii) Regional distribution of neurotransmitter uptake
The uptake of each

neurotra~smitter

into each brain

region employed in this study was investigated.

The method

employed was similar to that outlined above in methods
except that all these brain regions were studied for each
neurotransmitter.

The media used was that described by

Snyder and Coyle (1969).
The results are expressed as Particulate: Medium ratio
calculated as CPM/mg protein/Incubation time: CPM/ml. supernatant.
viii) Effect of calcium in 1-norepinephrine release
induced by hi-potassium depolarization
The role of calcium in the release of norepinephrin'e
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and its consequent effect on uptake was studied.

The

hypothalami of ten animals were pooled and divided into
equal aliquots.

Preincubation media used were as follows:

(1-2) hi - K+ (45mI~ ) plus ca++ (2.5 mM), (3) normal Kreb's
(2.5 mM Ca++) and (4) hi-K+ less Ca++.

The hi- K+ media

was prepared by equimolar replacement of Na+ by K+ .

The

CSR aliquots were incubated in twice the normal incubation
medium volume resulting in a protein concentration of 0 .24
mg/ml.

Incubation was carried out at 37°c for 15 minutes

with continuous oxygenation of the media with o 2 :co 2 (95:5).
The tubes were then centrifuged at 15,000 x g for 15 minutes
and the resultant pellets reconstituted with modified Kreb's
(i.e. no ca++ + 0.1 mM EDTA) in half the volume used for
the preincubation.

To tube #1 was added the diluent for

the neurotransmitter.

To the second tube was added a cal-

culated amount of unlabeled neurotransmitter required to
completely refill the synaptosomes (to 1 ugm/g tissue wet
weight).

Tube 3 received neurotransmitter diluent as did

#4 and all tubes were incubated for 30 minutes at 37°c.
Following centrifugation at 15,000 x g for 15 minutes the
pellets were resuspended in modified Kreb's media to which
H3-l-NE was added to achieve a resultant concentration of
0.1 uM and four one ml. aliquots of each tube were incubated
at o 0 and eight one ml . aliquots were incubated at 37°c for
10 minutes .

All tubes were then centrifuged at 13,000 x g

for 60 minutes in a Sorvall RC-2B centrifuge.

The pellets

were solubilized in the usual manner described in the gen-
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eral methods.

The data was calculated as ngm H3 -l-NE/mg

protein/10 minutes and expressed as percent of control.
ix)

IC~ 0 for some representative tricyclic antidepressants

The ability of tricyclic antidepressants to block the
uptake of labeled neurotransmitter by 50 percent (i.e. Ic 50 )
was studied by varying the concentration of antidepressant
using 4 concentrations increasing progressively by one
order of magnitude. The uptake of neurotransmitter calculated as ngms H3-l-NE/mg protein in the drug treated
samples were then compared with an untreated control and
expressed as a percent of control.

The concentration of

drug resulting in uptake representing 50'/o of control was
determined graphically and described in the results.
x-xi) Protriptyline - acute and subacute time course
Protriptyline was administered intraperitoneally
either acutely (20 mg/kg) or subacutely (lOmg/kg ) at varying
times prior to sacrifice as stated in the results.

Acute

refers to a single injection prior to sacrifice, whereas,
subacute refers to 6 consecutive days of injections.

On

any given day two animals from each treatment condition was
represented to randomize day to day experimental variations.
The animals were sacrificed at approximately the same time
each day necessitatingaschedule of injection running throughout the day (i.e. 5:00, 9:00, 11:00 A. M. and 11:00 P. M.).
Three determinations were made for each condition (i.e.

o 0 c and 37°c).

Incubations were performed in modified Kreb's
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media (no Ca++ + O.lmM ED'rA).
xii)

Protriptyline - chronic time course

One hundred animals were randomly assigned into five
groups of twenty animals each.

These five groups were ad-

ministered either saline or drug beginning on five consecutive days.

Within each group of twenty, four groups of

five animals each represented either saline injected controls or 2, 6 and 24 hour post-protriptyline (10 mg/kg i.p.)
injected treatments.

The brains of 5 animals in each group

were pooled prior to homogenization and the uptake study
was carried out over the course of 5 days after 18 consecutive days of injections for each group of twenty animals.
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c.

Results and discussion:
Included in the results sections are discussions per-

taining to the individual experiment which serve to develop
a sense of continuity and an appreciation for the course of
investigation taken in this thesis.

The general discus-

sion to follow considers the results of the research presented here as it relates to more general considerations of
the possible mechanism(s) of action of tricyclic antidepressants.
The terminology used in the literature with respect to
neurotransmitter transport studies is governed largely by
the methodology employed (Graefe, 1976).

Although the

definitions reviewed here are not strictly adhered to in
the literature, it is useful to describe the differences
and establish the terminology used in thi:s report.

"Uptake"

of amines can be defined as transmembranous flux into the
cell regardless of whether or not intracellular accumulation of the substrate occurs.

Many studies attempt to

measure "net uptake" which takes into account the accumulation of unchanged amine by the tissue preparation.

The

tissue preparation can lose accumulated amines by MAO metabolism and a common approach is to inhibit MAO in an attempt to obtain an estimate of net uptake.

The use of

amines which do not undergo metabolism by M
.AO (e.g. metaraminol) is an alternate approach to obtain a measure of net
uptake.

In either case the measurement only approaches the

tm.e value of net uptake because exchange processes are
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usually not considered by investigators.

There is suffi-

cient evidence to suggest that both hetero-exchange as well
as homo-exchange processes do occur (Cohen & Lajtha, 1972;
Levi et al., 1976).

Many studies use short incubation times

to maximize the magnitude of unidirectional flow of substrate and prolo:1ged incubation usually results in a deviation from linearity.

"Re-uptake" refers more to the process

in-situ and i :s inappropriately used as a synonym for uptake.
This thesis utilized the term uptake to represent an apparent accumulation of amines and assumes that exchange processes are not significant over the short incubation times
used.
General:
The reproducibility of the brain dissection procedure
is reported in table 1 and compares favorably with the values
reported by Glowinsky and Iversen (1966).

Since the bound-

aries differ some, the difference in values between those
published and reported here appear to be reasonable.

The

weighed brain regions were carried through the homogenization procedure and the functional relationship between the
wet weight of brain tissue for a given brain region and the
resultant concentration of protein in the I M was determined
as shown in figure 1 for the hypothalamus.

From the inter-

section of two regression lines (i.e. y on x and x on y) the
mean values of both variables are obtained.

From these

values corrections for dilution can be made and the appropriate relationships between mg protein (as a crude measure
of synaptosomal concentration) and a gram oi' tissue wet weight
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Table 1.

Reproducibility of the brain dissection pr ocedure

Brain region

Tissue wet wei ght (X ± s.e.m.)

Hyp othalamus

133 ± 8

Forebrain

199 + 8

Striatum

85

+

4

Mean weights for various brain regions dissected from 24
animals.
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Functional relationship between brain tissue wet
weight and resultant protein concentration in the
incubation medium.

Figure 1.
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can be formulated.

One gram of forebrain, hypothalamus and

striatum are equivalent to 460, 300 and 285 mg protein
respectively.

Conversions from mg protein to grams wet

tissue weight were made using these relationships.
i) Neurotransmitter integrity
The functional integrity of the substrates used in biochemical systems of the type reported here is an important
consideration with respect to interpreting the results.
Structual changes of the substrate molecule can result in
drastically altering the observed kinetic constants as well
as possess inhibitory properties themselves as outlined inthe
literature review.

Monitoring the integrity of the neuro-

transmitters is important and' can be accomplished in at
least two ways.

A simple method is to use chromatography

to identify the substance by separating it from closely
related molecular species.

The procedure outlined by Giese

et al. (1967) and reported here clearly resolved all three
neurotransmitters with virtually no overlap in the resultant radio-chromatogram shown in figure 2.

De-aminated and

0-methylated metabolites were shown to possess clearly distinguishable spots on the developed chromatogram.

The thin

layer chromatographic (TLC) procedure was performed between
series of experiments on both the unlabeled stock solution
as well as the radioactive neurotransmitter.
A method for the detection of specifically inhibitory
contaminants in radioactive substrates is described by
Timpton et al. (1977).

The advantage of this procedure is
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Figure 2.

Integrity of radioactive neurotransmitter substrates determined by thin layer chromatography.
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Figure 3.

Effect of incubation time upon the uptake of
H3-l-NE into hypothalamic crude synaptosomal
homogenate.
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minutes).

Similar results were obtained for DA uptake into

striatal CSR.

These results agree with those published

(Coyle and Snyder, 1969; Snyder and Coyle, 1969).

Serotonin

uptake was linear for six minutes and this value agrees
exactly with that reported by Shaskan and Snyder (1970).
Wong et al. (1973) demonstrated linearity for 5HT uptake for
at least 3 minutes and the difference may be accounted for
by the use of a 5 minute pre-incubation or equilibration of
the IM prior to introducing the radioactive neurotransmitter
and as well as a lower incubation temperature (30°c).

One

more complicating factor includes the use of a velocity
term as the ordinate of the time course curve presented by
these investigators.

The velocity term (nM/mg protein/3

min) requires each value for uptake at each time point to
be corrected for uptake over 3 minutes.

Making the appro-

priate correction from the velocity term to a concentration
term (nM/mg protein) results in a linear function for at
least 5 minutes .

As a result of these experiments, incu-

bation times for the uptake of NE and DA of 10 minutes were
established and 5 minutes for 5-HT.

The Tissue: Medium

ratio shown in figure 3 demonstrates that the process at

o0 c

seems to be one of adsorption or diffusion whereas at

37°c a concentrative phenomenon appears operative with
ratios as high as 4.

Dopamine uptake gave ratios one order

of magnitude higher than those of 5-HT or NE.

The tremendous

concentrative power of dopaminergic nerve endings in the
striatum may be as a result of finer nerve terminals
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resulting in increased surface area for uptake as suggested
by Glowinski and Iversen (1966).
iii) Synaptosomal concentration versus uptake
The concentration of tissue in the incubation medium
was shown to vary considerably as a result of the variation
in the dissection procedure.

Another source of this type of

variation is the physical size of the brain which varies
with the age or weight of the animal.

Differences in pro-

tein concentration (assumed to be a measure of synaptosomal
concentration) was studied in order to understand the nature
of this variable and apply whatever corrections seemed necessary.

The results shown in figure 4 for H3-l-NE are

representative of the results found for the uptake of
labeled 5-HT and DA.

The points represent the mean of 3

determinations with the coefficient of variation less than
10% for values above 0.5 mg protein per ml. of I M.

Values

below 0.5 mg had a much larger degree of variability associated with their means.

The resultant curves were calculated

using the original data points by polynomial regression.
The data was shown to be satisfied best by the second degree
polynomial equations shown in the figures with their attendent levels of probability.
Two interesting points can be made by observation of
figure 4. First, the ordinate is expressed as uptake in
ngms H3-l-NE corrected for mg protein. Theoretically, if
increasing synaptosomal concentrations results in an increase
in uptake described by a linear function, one might expect
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Figure 4.

Effect of synaptosomal concentration in the
incubation medium upon the uptake of H3-l-NE
into hypothalamic crude synaptosomal homogenate.
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that uptake corrected for mg protein would be a straight
line with a slope close to zero.

At concentrations of pro-

tein greater than 0.5 mg/ml. this theoretical curve appears
to be approximated fairly well.
The tremendous increase in uptake demonstrated at low
synaptosomal concentrations may be explained by an increase
in membranous surface area.

Since the uptake is increased

for both O and 37°c one might conclude that the increase is
due to adsorption to the membranous particles whose surface
area increases tremendously as a result of dilution.

Concen-

trations above 0.5 mg/ml. may reflect a state where by a
certain degree of clumping occurs resulting in minimizing
the surface area exposed to media substrate.

This clumping

effect appears not to increase tremendously over the range
0.5 - 1.1

mg protein/ml. I M although a slight decline in

uptake may be detected with increasing concentrations of
protein.
Secondly, it may be noted that the difference between
uptake at 37°C and o0 c is constant for any synaptosomal concentration.

This finding is important for it implies there

is no effect of packing upon the measure of protein.

Inter-

estingly, the relationship holds for low synaptosomal concentrations where, admittedly, the variability is high.

An

attempt was made to stay within the specified range where
variability was lowest.

Similar relationships for striatal

and forebrain tissue were found and the critical values
obtained were 0.16 and 0.25 mg protein per ml. I M respectively .
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iv) The effect of calcium and ethylenediamine-tetra
acetic acid
The results of manipulating the calcium concentration
in the media are presented in figure 5.

A one-way analysis

of variance of this data resulted in rejection of the hypothesis that the means were equal at P<.005 (Fobs=33.9 compare
with F(5, 26;0<=.005)=4.38).

An Fmax test for h omogenity of

variance demonstrated no violation of the assumption.

A

Student-Neumen-Keuls test for differences between treatment
means indicated that the Snyder and Coyle (1969) medium
resulted in uptake significantly different from that
obtained with normal Kreb's medium(Snedecor and Cochran,
1967).

When calcium was removed from the medi-u:r: and 0.1 :mM

EDTA added, the uptake into hypothalamic synaptosomes was
shown to be significantly greater than the value obtained
using the mediUJ:Jof Snyder and Coyle (1969).

Higher concen-

tration of EDTA resulted in attenuation of the response.
Much mystery still surrounds the role of calcium in
stimulus-secretion coupling mechanisms of neurotransmitter
release (Rubin, 1970; Phillis, 1974; Baldessarini, 1975).
As has been pointed out earlier in this report, preliminary
experiments were performed using the mediumdescribed by
Snyder and Coyle (1969).

The rationale for its use was

never made clear in the literature.

In 1968, Snyder et al.
reported the results of kinetic experiments of racemic H3NE in brain slices.

The

medi~ m described

was both normal

Kreb's and an ascorbate, EDTA and pargyline supplemented
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Figure 5.

Effect of altering calcium concentrations in the
incubation media upon H)-1-NE uptake into hypothalamic crude synaptosomal homogenate.
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Kreb's.

The authors suggested that EDTA and ascorbate

reduced auto-oxidation and pargyline prevented the formation
of deaminated metabolic products of NE, but calcium levels
were not reduced.

Subsequently, Snyder and Coyle (1969)

published the use of their calcium reduced

mediu~and

it has

been used in subsequent studies with no attendant discussion.
EDTA is a chelator of divalent cations.

The molar

ratio of divalent cation to chelate molecule is, at the
theoretical limit, equal to two.

Since EDTA possesses four

carboxylic acid groups it is theoretically possible for two
calcium ions to electrically neutralize one EDTA molecule .
EDTA , however, is not specific for chelating calcium,

~artell

and Sillen (1964, 1971) report the metal chelate stabilities
of EDTA to be greater for Cu (11), Zn (11) and Fe (11) by 70,
49 and 30 % than for calcium.

Magnesium has a stability

constant 23% lower than calcium.
Complex ion-chelator formations may also occur in acidic
media by protonation of the amine groups.

Therefore , it is

with considerable conserative bias that the theoretical
stoichiometric limit of 2 moles of ca++ required to form a
complex with one mole of EDTA is used to calculate divalent
ion equivalency in the various media employed.

Theoretically

then, 0.13 mM EDTA would complex 0.26 mM ca++ rendering the
media of Snyder and Coyle equivalent to 0.99 mM ca++Kreb's .
In consideration of the conservativeness eluded to above, a
ca++ concentration slightly higher than this might be more
equivalent to the Snyder and Coyle medium .
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In a separate experiment the uptake of 1-NE into hypothalamic CSH was measured using the Snyder and Coyle medium
compared with 1.25 mM ca++ Kreb's.

The results, analyzed

using a two-tailed t-test did not show the means to be
significant at P(.05 although the 1.25 mM ca++ mean value
obtained was approximately

99~

below the value obtained

using the Snyder and Coyle medium.

Acceptance of the null.

hypothesis suggests that the two media may be equivalent
with respect to the availability of ca++ ions.
The media of Snyder and Coyle was chosen in an attempt
to duplicate the experimental protocol and compare the
results as an aid to characterization of the system.

Sub-

sequent to these preliminary studies use of the med:i.u;-r.was
questioned and prompted this experiment.

The choice of

deleting calcium and adding EDTA was made using purely
theoretical considerations.

Since uptake studies attempted

measuring unidirectional flux it was reasoned that efflux
of endogenous amines in calcium enriched media might confound the results.

Indeed both homo-and hetero-exchange

processes are known to occur in transport systems of neurotransmitter amino acids (Cohen and Lajtha, 1972).

,1

Pre-

venting the calcium dep·e ndent process would serve to reduce
the accumulation of label by reducing its specific activity
in the IM.

Controlling dilution by calcium-independent or

spontaneous release of endogenous neurotransmitter is not
possible and should be considered as a source of error in
any estimate of unidirectional transmembranous flux of
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neurotransmitter molecules.
The results indicate that removal of calcium, up to a
point, does result in an increase in the value of uptake.
Increasing the EDTA concentration beyond 0.1 mM results in
a dose dependent decline in uptake.

Interestingly, Rajan
et al. (1977) reported a dose dependent inhibition of H3-NE

binding by metal chelators in mouse cerebral vesicles in
vitro.

It is possible then that high concentrations of

chelating agent interfere with metal coordination complex
formation within vesicles.

It is also possible that since

the chelating agents bind to copper and iron, high concentrations of chelators may interfere with cell respiratory
l. .
th ese me t a 1 ions.
.
processes requiring

Either mechanism may

result in the attenuation of uptake demonstrated at high
EDTA concentrations.
Blaustein et al. (1972) demonstrated a 37% decrease in
synaptosomal norepinephrine release from a calcium-free
normal Kreb 's medium compared with 2.5 mM ca++ normal Kreb's.
The magnitude of this release, calculated from the data
provided in the paper and making the assumption that one
rat brain weighs approximately 2 grams, results in a value
of 2.2 ng NE/g wet weight/min released into the normal
Kreb's medium and 1.45 ng NE/g wet weight/min in ca++_free
Kreb's.

The data presented in figure 5 demonstrates a 54%

increase in uptake using a ca++_free EDTA-enriched medium
when compared with normal Kreb's.

The value of uptake

obtained in the experiments described in this thesis are
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5.5 and 8.5 ng/NE/g/min in normal Kreb's and calcium free
EDTA enriched Kreb's respectively.

These figures indicate

that ca++ independent or spontaneous neurotransmitter
release may contribute significantly to homoexchange processes confounding a measurement of unidirectional flux into
synaptosomes.
Kant and Meyerhoff (1977) studied the effect of calcium
on norepinephrine release from hypothalamic tissue minces.
These authors compared the release of NE in a normal Kreb's
versus a calcium free Kreb's media at

o0 c

and reported a

seemingly insignificant increase (5%) of release in normal
Kreb's.

Lane and Aprison (1977) reported all three neuro-

transmitters (i.e. NE, DA & 5-HT) to behave similarly.

Since

the release of endogenous neurotransmitter can be minimized
by modifying the media all subsequent experiments reported
here have been performed with calcium-free EDTA enriched
(O.l mM) Kreb's media referred to herein as "modified Kreb's".
v) Kinetics
Characteristics of transport systems of t h e type used
in this study have been determined using relationships described by enzyme kinetics.

Linear transformations of the

rriichaelis-Menten equation leads to graphical techniques for
the determination of kinetics constants (i.e. Km and V
).
max
A number of linear transformations are possible and most are
reviewed in standard texts on enzyme kinetics (Roberts, 1977).
In recent years a growing number of investigators have

be~

come concerned with the validity of the methods employed.

72

The most popular method by far is that of Lineweaver -Burk
(1934), although Dowd and Riggs

(196~)

demonstrated that

this method led to least accurate determinations of kinetic
constants whether the curve was plotted by eye or using the
r

method of least squares.

The Hofstee plot (S/v vs. S) was

considered the most favorable since it was viewed that of
the two variables Shad less error associated with it than
v.

Estimates of kinetics constants can be obtained using

non-linear statistical techniques (Cleland, 1967; Wentworth ,
1965a, b) but these methods require iterative procedures and
have not demonstrated popularity among biochemists.

Elmore

et al. (1963) applied a linear regression technique to the
Lineweaver-Burk transformation which accounted for the
variability associated with each data point.

Wilkinson

(1961) applied a similar technique except that a weighting
factor was used with the assumption that the distribution
of the observations of the velocity about a given substrate
concentration was directly proportional to the magnitude of
the velocity.

This assumption can be shown to be true in

many biological systems where analysis using MichaelisMenten kinetics apply.

Probably the best method from the

standpoint of a mathematical approach to the determination
of kinetic constants is that of Wilkinson (1961) although
it requires the assumption of normally distributed data as
any parametric method does.
Recently, a graphical method for the ·analysis of kinetic data called the direct linear plot (DLP) has been
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re·p orted by

~isenthal

and Cornish- 3 owden (1974).

_Ton-para

metric statistical considerations supporting the use of t his
method have been describ ed (Cornish- Bowden and Eisenthal,

1974; Trag er and Porter , 1977).

Th e advantage to the direct

linear plot , over the other methods as pointed out by the
authors is that it is simple to construct with kinetic constants read directly off the graph without calculations as
is done with reciprocal plots.

It is extremely sensitive

to outliers or abberant observations and provides accurate
determinations of kinetics constants.
The kinetics data for 1-NE uptake into hypothalamic
CSE was analyzed using a number of different methods , some
graphi cal and some statistical.

Th e results obt ained by

various methods are shown in table 2.
pare.

Th e easiest to pre-

The kinetics constants obtained were compared and the

results obtained indicate the ·direct linear plot to b e as
good an estimator of the kinetics constants obtained by
either Wilkinson (1961) regression or the standard parametri c linear regression model described by Elmore et al .

(1963).
The DLP was used in the calculation of all kinetics
data reported here and is described briefly to acquaint the
reader with the technique.

The interester reader is refered

to the original references of Cornish- Bowden and Eisenthal for
the theory and a more thorough discussion of techniques and
applications.

The DLP is so named " ••• because it represents

each observation by a straight line, ••• "and utilizes the
concept of plotting data in parameter space rat h er than

Table 2. Comparis·on of methods used to determine kinetics constants for H3 -l-NE uptake
into rat hypothalamic CSH
Km {uM)

Ymax (ng/mg prot/lOmin)

Method

Reference

l/v vs. l/S

Lineweaver-Burk, 1934

2.434

S/v vs. S

Woolf plot
(Haldane & Stern, 1932)

0.236

2.40

v/S vs. v

Augustinson (Hofstee )

0.262
-.018

2.539
±.098

reduced weighted
regression
assuming constant
coefficient of
variation

Johansen & Lumry, 1961;
Wilkinson, 1961

0.308

2.85

0.239

+

-J
-i::..

0.276

2.628

weighted linear
regression

Steel and Torrie, 1960;
Elmore, Kingston &
Shields, 1963

0.235

2.340

Direct Linear
Plot

Eisenthal & CornishBow den, 1974
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observation space.

The ordinate is labeled Vmax and the

abscissa Km and the corresponding set of observations, i.e.
v and S, are represented as points on the abscissa and
ordinate, respectively.

A line is drawn through each set

of data points and is continued as far as possible into the
first quandrant.

The data for 1-NE kinetics is shown in

figure 6 using the DLP.

It can be dem onstrated that for n

pairs of observations there exists 1/2 n(n-1) intersections
of the lines extended into the first quandrant.

The non-

parametric theory specified the most likely unbiased
estimator of the parameters to be determined is given by the
point associated with the median of all interecting lines.
That point can be taken from the associated values of the
axes labeled Km and Vmax·

For 6 data points there are 6/2

(6- 1)= 15 intersections with the median being the point
described between the points designating the seventh and
eighth intersecting lines.

Two intersecting lines yields

one point whereas three intersecting lines corning close to
the same place can be shown to be represented by three
points.

Counting may begin from the low left corner of

quadrant 1 and proceed to the upper right.

The first circle

represents 4 intersecting lines or 5 intersections.

Since

we are interested in that intersection which falls between
7 and 8, that intersection must be in the second circle (i.
e. between intersections 4 and 9).
Comparisons of the kinetic data obtained using the DLP
with reported values are presented in tables 3, 4 and 5 for
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'Direct Linear Plot' of H3-l-NE uptake into
hypothalamic crude synaptosomal homogenate.

Figure 6.
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Table 3.

Kineti c constants obtained for norepinephrine uptake using substrate
concentrations in the high affinity range.

Km

(uM)

v

(nM/gm¥min)

Reference

Remarks

. 0.4

0.11

Ross and Renyi, 1964

d, 1-NE mouse
cortex slices

, 0.48

0.71

Salama et al., 1971

d, 1-NE rat
brain slices

0.4

1.66

Snyder et al. , 1968

d,1-NE rat
brain slices

0.2

N/A

Ross and Renyi, 1975

1-NE rat brain
synaptosomes

0.5

N/A

Ross and Renyi, 1975

1-NE rat brain
slices

Shaskan and Snyder, 1970

d, 1-NE
synaptosomes
hypothalamus

This study

calcium-free plus
EDTA enriched
medium

0.2 - 0.4

0.227

0.33 - 0.40

0.413

-..J
-..J

Table 4.

Km
(uM)

Kinetic contants obtained for serotonin uptake using substrate concentrations
in the high affinity range.

v

(nM/g ~atnin)

Reference

Remarks

0.7

0.23

Ross and Renyi, 1969

mid-brain
mouse slices

0.1

1.13

Wong et al., 1973

rat brain
synaptosomes

Shaskan and Snyder, 1970

rat brain
synaptosomes

0.14-0.31

o. 66-0.82

0.08

N/A

Ross and Renyi, 1975

rat brain
synaptosomes

o.6

N/A

Ross and Renyi, 1975

rat brain
slices

0.15

0.84

This study

Medium of
Snyder and
Coyle ( 1969)

N/A The information was not available in the cited paper.

-....]

m
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Table 5.

Km

v

(uM)

(nM/g ~atnin)

0.31-0.4

4.08-5.0

0.13

:

Kinetic constants obtained for dopamine uptake
using substrate concentrations in the high
affinity range.

5.08

Reference

Shaskan and Snyder, 1970

This study
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NE, 5-HT and DA respectively.

The data appears in good

agreement with the values reported by other investigators.
Small differences may be due to the tissue preparation used
(slices vs. synaptosomes) as well as the duration of incubation which can result ·in larger differences in the V max
values.

These results suggest that the experimental proto-

col as used here yields results that are similar to those
obtained in other laboratories.

Further support for this

conclusion is offered in a review of the in-vitro data of
section ix.
vi) Subcellular distribution of H3-norepinephrine
uptake

An attempt to characterize t h e functional integrity of
the synaptosomal transport system was made by separating
some of the constituents of the CSH.

The synaptosomes are

known to be confined to a region on the sucrose gradient
corresponding to 1.1 molar (Gray and Whittaker, 1962).
Mitochondria are known to sediment below 1.2 M sucrose and
monoamine oxidase activity is taken to be a mark er for
mitochondria (Laduron, 1977).

In figure 7 it can be ob-

served that the radioactive neurotransmitter concentration
is highest at the synaptosomal fraction and some label can
be seen associated with myelin and microsomes as might be
expected due to adsorption.

The supernatant possesses a

large degree of label but little or no ri!.A O activity.

This

evidence suggests that t h e CSH is selectively incorporating
radioactive n eurotransmitter wit hin the synaptosomal fraction
and there is little contamination of uptake into either
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Figure 7.

Subcellular distribution of nreviously accumulated H3-l-NE into hypothalainic crude synaptosomal homogenate.
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mitochondrial or microsomal components.
vii) Regional distribution of neurotransmitter uptake
The selection of brain regions for studying the uptake
of different neurotransmitters was based on the rationale
that selection of brain regions with a high concentration
of nerve terminals would result in a greater degree of
uptake compared with non-specific binding.

Snyder and Coyle

(1969) used hypothalamus for norpeinephrine and striatum for
dopamine uptake studies.

Kuhar et al. (1972) used forebrain

for serotonin uptake studied.

Confirmation of this selection

of brain regions was attempted by studying the uptake of each
neurotransmitter in each brain region.
results.

Figure 8 depicts the

Each value and its associated variation represents

the results obtained from 3 animals.

Dopamine uptake is

unquestionably greatest into the striatal tissue although a
fair amount of dopamine can be taken up into hypothalamic
tissue presumably into noradrenergic as well as dopaminergic
neurons to some degree (Coyle

&

Snyder, 1969).

Norepin- ,

phrine uptake, although large in the striatum, may represent
uptake into dopaminergic and other nerve terminals.
Hokefelt (1970) estimated the noradrenergic contribution
towards total catecholamines in the striatum to be 5% based
on histochemical observations.

The selection of tissue for

uptake is similarly clear with greatest values obtained for
serotonin uptake into forebraintissue.
The choice of NE into hypothalamus appears to be
governed more by tradition and concentrations of all three
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Figure 8.

Regional distribution of high affinity neurotransmitter uptake.
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neurotransmitters are shown to be equivalent in the hypothalamus (Anden et al., 1966).
viii) Effect of calcium in 1-norepinephrine induced
release by hi-potassium depolarization
This study was prompted by the observation that a
tremendous degree of variability occured in the in-vitro
measurement of uptake after intraperitoneal administration
of protriptyline.

In an attempt to uncover the source of

this variability it was reasoned that endogenous neurotransmitter may influence uptake.
are presented in table 6.

The results of this experiment

Although the data presented here

could not be shown to differ using an analysis of variance,
the data can be taken to . suggesta trend.

Stimulation of

release of endogenous neurotransmitter by hi-K+ depolarization resulted in greater uptake when compared with tissue
identically processed in normal Kreb's.

Depleting the

synaptosomes by hi-K+ in the absence of ca++ results in a
value of uptake intermediate between what can be considered
a greater and lesser degree of emptying.

Refilling the

synaptosomes with unlabeled NE and subsequently incubating
with labeled neurotransmitter results in a value higher
than that obtained for the same treatment except for refilling.
The results appear predictable.

Removing neurotrans-

mitter from the synaptosomes may reasonably result in
greater uptake by increasing the physical capacity to
accumulate neurotransmitter taken up.

Kant and Meyerhoff

(1977) demonstrated at 17.5% increase in NE released by
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Table 6.

Effects of Hi-K+ depola,ization pretreatment upon
subsequently measured H -1-NS uptake

Tissue: Medium ratio. (CPM/gm. brain:C PM/ml. supernatant)
Percent of Control
(r-foans ± s. e. m.)

-· rr+
h l.n..

Normal Kreb's

100

±

27

without ca++

160 + 43

139 + 18

NE prefilling

Hi-K+
with ca++

177 + 49
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Hi-K+ in the absence of ca++ which can be used to explain
the reason for an increase in uptake over normal Kreb's.
The fact that uptake is increased in normal ca++ Hi-K+ as
opposed to ca++ free Hi-K+ media suggests that exogenously
administered NE may equilibrate with both neurotransmitter
compartments (i.e. vesicular and cytoplasmic).
The increase in uptake measured in the refilling condition appear inconsistent with notions regarding the distribution of neurotransmitter within the synaptosome.
Classical theory considers norepinephrine to be bound with
a protein, chromagranin A, ATP and Mg++ (Cooper, Bloom &
Roth,

197~).

It is also postulated that a mobile pool

exists within the vesicle (Kirshner, 1962).

The exact

relationship between the uptake of exogenously administered
norepinephrine and subsequent compartmentalization between
vesicles and cytoplasm is not lmown.

Release studies using

preloading techniques make the assumption of equal distribution inherently.

It might appear then that previously

accumulated norepinephrine distributes itself to some
extent in both compartments and in doing so may result in
inhibiting any further uptake of exogenously applied neurotransmitter by mass action.

The results indicate quite the

contrary and may be interpreted to reflect an uneven distribution within compartments.

Although admittedly specu-

lative, one explanation may be that recently accumulated
neurotransmitter is inactivated or bound by vesicular complexing components.

This binding would reduce the outward
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flow of previously accumulated neurotransmitter and may
result in a priming effect on intra-vesicular Mg-ATP-protein
complex.

Alternatively, high cytoplasmic concentrations of

accumulated NE may result in a greater rate of exchange so
that uptake may appear to increase overall but net uptake
does not change.

Answers to these questions are experiment-

ally approachable and in view of the fact that Grahame-Smith
and Parfitt (1970) report similar results with 1-tryptophan,
a study of this type may help to elucidate the compartmentalization of exogenously administered neurotransmitter.
ix) ICso for some representative tricyclic antidepressants
There are, as in obtaining kinetics constants, different methods used to calculate the
respect to particular response.

rc 50

for a compound with

Ross and Renyi (1967)

introduced the concept of an uptake blocker standard (l.O x
l0- 4M cocaine) by which other compounds of varying doses
could be compared.
inhibition and the

The data is reported as percent of total

rc 50

calculated by graphic observation of

the resultant log dose-response curve.

Another alternative

is to use a vehicle-treated (or untreated) control and compare the value obtained for drug treated samples with those
obtained for controls and represent the data graphically as
in the log dose-response curve of figure 9.

Th e results in

this figure are the means obtained in four separate experiments when drug treated samples wher·e compared with an untreated control.

The resultant points were connected by a

straight line using visual methods and the point at which
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Figure 9.

Graphical determination o! IC5o's.
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uptake is equivalent to 5<Y/o of control was taken directly
by dropping a perpendicular line to the log dose axis.
Use of the logarithmic transformation for biological
data has statistical considerations as its basis.

Finney

(1971) demonstrates how biological data of dose versus
response are typically skewed and a logarithmic transformation results in a normal frequency distribution thereby
rendering

a.~alysis

of the data to the application of linear

regression and correlation models.

The assumption of lin-

earity over a large portion of the dose-response curve is
unjustified except for rough approximations (Goldstein,
1967).

The use of more accurate methods of determining

values of inhibitory constants such as probit analysis can
be used for critical experiments.

The objectives of these

experiments are most conveniently served by the graphic
method described.
The results of calculated

rc 50

1

s are compared with

published results for serotonin, norepinephrine and dopamine in tables?, 8 and 9 respectively.

Review of these

results indicates that the obtained values correlate well
with published values.

The generalizations described in the

literature review for the uptake blocking characteristics
of tertiary versus secondary amines is supported by the data
summarized in tables seven through nine.

Tertiary amines

appear more effective in blocking serotonin uptake whereas
secondary amines are potent inhibitors of norepinephrine
uptake.

There appears to be no obvious separation of effects

Table 7.

Norepinephrine uptake IC~ 0 's* for representative secondary and tertiary
amines of the tricyclic antidepressant class of drugs.
tertiary

second~y

PRO

0.0 6

0.043
(4)

AMI

DMI

IMI

0.03

0.2

Ross and Renyi, 1967a

0.03

0.15

Shaskan and Snyder, 1970

0.05

1.0

0.055

DOX

0.65

Reference

Horn et al., 1971

0.00 6

Carmichael and Israel, 1973

0.008

Maxwell et al., 1974

0.003

0.028

0.054

0.075

2.4

0.1

(2)

(4)

(2)

*Ic 50 1 s expressed in micromolar (uM)

Ross and Renyi, 1975
0.51
(2)

This study
(number of experiments)

'°0

Table 8.

Serotonin uptake IC~ 0 s* for representative secondary and tertiary amines of
the tricyclic antidepressant class of drugs.
1

secondary
PRO

DMI

tertiary
IMI

0.285

2.3

AMI

DOX

Ref er enc es

0.49

Horn and Trace, 1974

1.1

0.14

0.18

Ross and Renyi, 1975

2

0.5

0.5

Squires, 1974
Ross and Renyi, 1969

4

5.8

0.5

Carlsson, 1970

8.3

2.7

2.7

3.3

0.3

0.67

Buus Lassen et al., 1975

4

6.0

0.6

0.8

Kannengiesser et al., 1973

9.1
(4)

4.5
( 2)

0.1
(4)

---

Shaskan and Snyder, 1970

*IC 50 1 s expressed in micromolar ( uM)

2.5
( 2)

This study
(number of experiments)

\.D
~

Table 9.

Dopamine uptake ICs 0 's* for representative seconday and tertiary amines of the
tricyclic antidepressant class of drugs.

tertiary

secondary
PRO

DMI

IMI

AMI

DOX

Ross and Renyi, 1967

80
6

50

8

5

50

16

(4)

*Ic

1

50

(2)

References

(4)

4

4
(2)

s expressed in micromolar (uM)
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Horn et al., 1971

This study
(number of experiments)

~
f\)
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of eit:'.1.er secondary or tertiary amines with respect to t he
inhibition of dopa.nine
x)

upta~e.

Protriptyline - acute tine course

The results of 6 animals in each treatment group given
20 ng/kg protriptyline i . p. are presented in figure 10.

A

one- way analysis of variance a:pplied to the data could not
demonstrate t:'.1.e differences
istically significant .

seen in this figure to be stat -

The data from an additional twelve

animals were combined for the control and 6 hour treated
groups .

The results of a comparison of treatment means

using a two- tailed t-test demonstrated significance at the
P . 05 level .

Variability in this system has been sh own to

be high throughout preliminary investigations of intraperi toneal administration of these drugs with subsequent
testing in-vitro .

It is important to note that the number

of subjects in the acute as well as the subacute study
represent individual animals.

The variability of the steady-

state levels of tricyclic antidepressants in plasma has been
shown to be high (Asberg et al . ,1971) and this phenomenon
may be reflective of the high variability observed in these
results .

In any event, there appears to be an effect of

blocking the uptake of 1- NE on acute administration of the
drug after six hours.
xi)

Protriptyline - subacute time course

Preliminary investi gations using a dosage schedule of
20 mg/kg daily resulted in t he deat h of a number of ani mals
within 8 to 14 days .

In virtually all cases of death,

Figure 10.
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distension of the ab domen was obvious .

Aut opsies performed

on t h e ani mals revealed t t e lower i n testin e to 1J e filled
wit h gas w:r.. er eas t h e upper intestin e and s t omac h was fill ed
wit h par t ially di g ested food .

I t was con cluded that pro-

nounced anticholinergic activity of the drug resu lted in
paraly sis of peristalsis with death due to starvation .
Gross behavioral observations of t h e ani mals prior to deat h
s h owed pro gressive weakening wit h diminish ed locomotor
activity .

The dose employed for t h e sub ac ute and chronic

study was reduc ed fro m 20 to 10 mg/kg to insure t h e survival
of t h e ani mals durin g the chronic study an d prov·ide a sourc e
for comparison to the suba.cute study .
Fi gure 11 illustrates t h e results ob tain ed fro m 10
animals per condition administered 10 mg/ kg protript ylin e
i . p.

Once a.gain application of a.n analy sis of varian ce to

t h e data. did not result in statistically si gnificant results .
The reduction of uptake observed a.t 2 h ours was 18% of
saline injected controls (S . I. C. ) .

Application of a number

of statistical methods including Winsorizing an d Tri ;nming
(Winer , 1971) did not result in establish ing differences
b etween treatment means .

The results t h en can only be ta.k en

as suggestive of a.n effect at 2 hours .
Ten metabolites for t h e tertiary

ami n e ~

i mipramine ,

have been identified an d t h e de gree of ca.t a.bolism of all
but t h e conjugated species have been studi ed in- vitro u sing
a rat liver microsomal pre-pa.ration (Bick el,19 66) .

Th e

tertiary amine is cata.bolized to its corresp onding se c ondary
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Figure 11.

Time course for the sub-acute administration of
protriptyline upon the uptake of H~-1-NE into
hypothalamic crude synaptosomal homogenate.
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a.mine a."1.d this represents t h e only major me tab olite formed
in-vitro.

Th e secondary a.mine attains peak plasma levels

within two h ours.

Subsequent metabolism of t he secondary

amine to a pr i mary amine or N-oxidati on or rin g hydroxylation is less than

1 CY,'~

of t h e total substrate concentration

within the parameters of the in-vitro test.

Th ese results

may reflect the metabolism in-vivo and may account for the
time course observed in the acute study.
Subacute administration, however, does not lead to a
clearly interpretable time course for the effect of uptake
inhibition.

In fact, variability is extremely hi gh at this

point wit h noticeable, although not statistically si gn ificant, increases in uptake above controls which may sugge st
a reb ound phenomenon of t h e neuronal ending to re-capture
lost neurotransmitter.

Th e sub acute data of figure 11 can

be interpreted in another way .

Instead of postulating a

clear-cut but relatively ineffec t ive decrease i n unt a ke at
two h ours as well as a small reoound i n cr ease ab ov e cont rols
a.t six and twelve hours, it is possible to view the results
a.s simply no effect after six days of drug.

The former view

has much conjecture associated with it, t he latter is more
nearly that necessarily obtained by strict stat istical int erpretation of the results .
xii)

Protri ptyline - chronic t i me cours e

The results of chronic (1 8 days) administration of
protriptyline upon the uptake of 1-NE into hyp ot halaoic CS H
are deuicted in fi gure 12.

Application of a one- way analysis

98
Time course for the chronic administration of
protriptyline upon the uptake of H3-l-NE into
hypothalamic crude synaptosomnl homogenate.

Figure 12.
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of variance resulted in rejection of the hypothesis of equal
oeans (F , 16 = 10.52, P .01) and the assumption of homogen3
eity of variance was not violated as determined by an Fmax
test.

Subsequent comparison of the treatment means was per-

formed using the Student-Neuman-Keuls multiple range test
and demonstrated statistically significant differences at

P .01 for control versus two hours , control versus six h ours
and twenty-four versus two hours .

Treatr:ient at twenty-four

versus six hours was shown to be significant at P . 05,
whereas, no statistically significant differences could be
demonstrated for either the two versus six hour or control
versus twent-four hour treatment groups.
The measure of dispersion about the means reuresented
in figure twelve are standard deviations and not standard
errors of the means as used in the acute and subacute figures.
Alth ough twenty-five animals were used in each treatment
condition, the effect of pooling allows them to be represented only as an n.l = 5.
with previous studies,

Even with relatively low n.l compared
the data obtained are so precise

that it may be concluded that the effect of pooling serves
to mask the individual variability

c~nsiderably.

One additional point worthy of discussion is that of
the variation observed between the control groups of the
acute, subacute and chronic studies.

The weights (and ages)

of the animals used in each of these studies varied considerably be cause selection of the animals used in these studies
was based

pri~arily

upon animal availability.

In the acute
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group the animals weighed approximately 300 grams and t h e
uptake value for t h e c ontrols in t hat group was approxi mately
0 . 6 as indicated in fi gure 10 .

Th e suba.c ute study employed

animals weighing 450 grams and the control uptake value of
0 . 3 can b e ob served from fi gure 11 .

Finally , th e chronic

group employed 200 gram ani mals and t h eir control values
wer e 0 .9 as depicted in figure 12 .

It is easy to conclude

that uptake is inversely proportional to the age or wei ght
of the animal .

Although each group had its own control , a

good argument can be made for t h e inappropriateness of
c omparing the results between groups because two variables
ar e known to differ i . e . treatment and the a ge of the anioals.
The ar gument is difficult to refute on t he oretical grounds
and no attemut to do so will be persued .

Instead, these

experiments will be repeated with post - pubertal a.Di mals prior
to publication .
A comparison of the maximal percent of uptaxe i nhib ition
with respect to t h eir own saline injected controls in t he
a cute , subacute and chronic studies are 56, 18 and 48 percent,
respectively .

If the consideration noted in t he preceding
I

paragra~h

turns out to be u..Djustified , then these values

alone sugg est that uptake inhibition is prominant durin g
either acute or ch..ronic administration and n ot nearly as
effective during subacute administration of protriptyline .
The results may sugg est t hat chronic adm nistration of protri~tyline

results in a long lastin g inhibition of the

transport carrier for l - 3 E uptake into the hyp othalamic CSE,
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unlike the results of the subacute experiment .

Since upt a ke

after subacute administration may be considered neither
prolonged

nor unidirectional, it appears that therapeutic

effectiveness would not be anticipated during subacute administration and this reflects the clinical picture very
accurately.

The prolonged effect upon chronic administra-

tion appears predictive of a therapeutic response and is
clearly temporally related to the therapeutic effect observed cl:i;nically.

The se results support the hypothesis that

tricyclic antidepressants may work by blocking re-uptake
of endog enous neuxotransmitter in-situ .
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GENERAL DISCUSSI ON
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A.

Interpretive constraints
One of the principal responsibilities of a scientist is

to attempt to remove or at least counter - balance the bias
which permeates his or her line of investigation .

A g ood

deal of bias is corrected for with the proper use of controls
but much bias remains at the level of assumptions made prior
to the experimental design .

Three assumptions have been

made and are discussed h ere to alert the reader to the limitations of the interpretations made h oth in t h e preceding
chapter and the conclusions to follow .

Th e first deals wit h

t h e assumption of unidirectional transmemb ranous fl ux of
n eurotransmitter into s ynaptosomes and h ow this ph enomenon
may confound the measurement of uptake .
tion

The second assump-

is t hat of no effect of endog enous neurotransmitter

levels upon uptake .

Fi nally t he assumpt ion of equival ent

protein binding of tricy clic antideuressants to phys iolog ic al
proteins present in t he inc ubation medi um is discussed .
Much of t h e experimental work reported here is concern ed wit h t h e characterization of the s ynapto soma.1 system used
to study t h e effects of intraperitoneally a dmi n istered drugs
by subsequent in- vitro testing .

The characterization lends

credibility to the proper functionin g of the s y stem in t hat
it clearly demonstrates the de gree to v1h ic h this sy stem cor.ipares with those used by ot her investi gat ors .

However , in

no way does it resolve critical issues with r espect to the
transport of 1- norepinephrine into synaptosome s .
On e such issue remaining unresolved is t hat re garding
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the extent to which neurotransmitter exchange processes
occur and may confound the measurement of a.-ri estima.te of net
uptake .

.An approach to resolving this question may be to

measure the specific activity of neurotransmitter located
in the incubation medium, the synaptosomal cytoplasmic as
well as vesicular fractions separately both before
after incubation at physiological temperatures.

~vid

The results

of these experiments may indicate whether endogenous neurotransmitter stored within vesicles, the cytoplasm or that
resulting from de novo synt hesis somehow contributes toward an exchange process •
.Another unresolved question is that of the relationship
between endogenous neurotransmitter content and the uptake
of exogenously applied neurotransmitter.

A review of the

literature suggests that endogen ous biogenic amine levels
are lowered upon chronic administration and turnover
appears to be increased.

These effects appear intuitively

concordant with what one might expect of uptake inhibitors ,
however, this interpretation presupposes that the effect of
uptake inhibition is responsible for the lowered levels.
The evidence comes from demonstrating the uptake inhibitory
characteristics of the tricyclic antidepressants as measured
in-vitro.

Lowered levels of endog enous amines may

~e

re-

s-ponsiole for a decrease in uptake and if t his is so, the
inhibition of uptake observed may be an indirect effect of
t h e drug .

This important question seems experimentally

approachable by comparing the effects of biogenic amine
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synth esis inhibitors upon uptake measured both in- vitro and
after parenteral administration with subs equent testing invitro .

Th e data presented in this

t h es~s

with respect to

neurotransmitter refilling of previously emptied synaptosomes sugg ests that levels of neurotransmitters can affect
uptake .

Snyder and Coyle (1969) renorted a decrease in up-

take of norepinephrine in animals previously treated with
reserpine as opposed to saline injected controls .

In

addition it is important to realize that compartmentation
of neurotransmitter within the neuronal ending may affect
uptake differentially .

Investigation of the pharmaco -

dynami c s of the tricyclics with respect to uptake inhibition
should consider the effect of pool sizes as well as total
levels of endogenous neurotransmitters .
The potencies of the tricyclics as uptake inhibitors
are taken from conc entration terms in- vitro whereas it has
been shown that the binding of tricyclic antidepressants
to plasma proteins is variable and does not reflect a clear
separation of effects between secondary and tertiary amines
(Barga et al ., 19 69) .

The in-vitro experimen ts therefore ·

necessitate an assumption of equivalent "::l inding to plasma
proteins for a direct domparison of potency to be considere d
legiti mate .

ProtriptyJ,ine and desmethylimipramine are

b ound to plasma proteins leaving only 8 . 0 and 8 . 4 percent
free in the plasma, respectively.

Imipramine and amitrip-

tyline are free in plasma to the extent of 4 . 2 and 3 . 6 percent, res pectively .

: ortriptyline however , i s 94 .5 percent

10 6

bound .

Since free drug is considered to be pharmacological-

ly active whereas t hat b oun d to plasma proteins are inactive ,
the relative degree of bindi ng may be an i:nportant variable
in ascertainin g meaningful potency ratios i n - vitro and invivo ( Glassma..n. et al., 1977) .

Although much work ha.s been

done in an attempt to correlate blood plasma levels with
the therapeutic effect (Alexanderson et al., 1973), little
has been reported on the relationship between t h e concentration of free drug and clinical outcome ( Glassman et al .,

1973, Muscettola et al., 1978 ).
B. Alternative mechanisms
Caution must be taken at this time to refrain from
concludin g that tricyclics mediate their t herapeutic effects by uptake inhibition or bloc xade.

The spectrufil of

phar macological activity of the tricyclic antidepressants
is not limited to uptake blockade .

In fact, two additional

biochemical effects are being sugg ested as possible determinants of the therapeutic effect of the tricyclics .
Edwards and Burns (1974) demonstrated t he ability of tricyclics to block MAO found in human platelets and rt.0th and
Gillis (1974) reported an ·1AO inhibitory effect of tricyclies in rabbit brain mitochondria .
Alternatively, tricyclics possess reasonable strong
antic h olinergic effects demonstrated both peripherally ,
usin g antagonism of carbach ol contraction of the guinea pig
ileum, a...'1d centrally by displacement s of E3-quinuclidinyl
benzylate, a potent muscarinic antagonist, from h omog enates
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of rat brain (Sayers and Burki , 1976; Snyder and Yammamura ,
1977).

Janow sky et al. (1972) review the evidence for the

efficacy of anticholinergics in the treatment of depression.
In addition to the effects suggested as components of
the thymoleptic effect, tricyclics possess other therapeutic
effects when administered in doses below that required for
the treatment of depression.

Wilkerson (1978) reported o

the ability of tricyclics to reverse ouab ain induced ventricular arrhythmias in dogs at doses be low that used for the
treatment of depression.

Similarly , protriptyline ha s b een

demonstrated to be effective in the treatment of hyp ersornnia
and t he narcolepsy-catalepsy syndrome after a single bedtime dose of 10 mg (Schmidt et al., 1977).
Other clinically effective antidepressants exhibit
different pharmacological profiles than the tricyclics .
Mianserin is not a very potent inhibitor of catecholamine
or serotonin uptake (Goodlet et al., 1977).

Eomifens ine

possesses weak a.nticholinergic activity but is very potent
inhibitor of dopa:nine uptake and has clinical psychostimulatory properties (fiunt et al., 1974).
Comparisons of the performance of tricyclics as well
as other clinically effective antidepressants in a number of
biochemical systems may serve to demonstrate the extent to
which each property (i.e. anticholinergic, uptake inhibition,
receptor binding affinity, Vi.AO inhibition, etc .) may either
contribute to or be nredictive of either the thymoleptic
effect or side effects.

These comparisons may sugge st a
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role for specific neurotransmitters or a balance of neurotransmitters in depression or any of t h e other clinical
entities in which tricyclics are or can be used.
One type of comparative technique is demonstrated in
table 10.

The table was compiled from all in-vitr o

dat~

reviewed in tables 7 - 9 as well as t he anticholinergic data
of Shein and Smith (1978).

Inclusion of the anticholiner-

gi c potencies was based upon availability of comparative
data for the particular tricyclics investigated and reported
in this thesis.

Unfortunately , comparative data across a

number of seconday and tertiary amines are not available
for the other -uronerties
mentioned.
.
3efore proceeding it is important to point out that a
similarly compiled table may possess a great deal more
pr edictive value if each of the biochemically determined
potencies were measured after chronic parenteral administration of the drug.

As Inch et al. (1973) point out, the com-

parison of drug effects in-vivo can only be considered valid
if the time course for the effect of each drug is determined and the time representing the optimal effects are used
to determine potencies .

This would necessitate perforoing

a time course for each drug after chronic administration .
Th e in-vitro comparisons then are performed with the understanding that they might not reflect the actual relative
potencies which may occur upon

c~ronic

administration of

the drug, however , it represents a starting point and a
source of comparison for data which will no doubt become

Table 10.

Sub
clase DRUG
of
TCA

s

E

c

0
N
D
A

PRO

DMI

~.
T
E
R
T
I
A
R

IMI

AMI

y

Summary of relative and absolute potencies of re~resentative secondary and
tertiary amines of the tricyclic antidepressant lTCA) class of drugs.
POTENCIES
UPT-.AKK Ic Ts TuM/ *
20
DA
NE
5-HT
+
+
+
5.3-1.4 .015-. 01 5.5-.5
+(5)

(2)

(2)

+ 01 60.± 10
3.3:!:.67 .025-.

(9)

(7)

+
+
.33-.09
1o75-.45
(5)

(5)

+ 01
+
i-07-.
.53-.1
(5)

(4)

+
+
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a vailable with future research .
To the left of the vertical doub l e line in table 10 a.re
the uptake inh i bitory potencies of t he t ricy clics with r espe ct to three neurotransmitters a s well a s the relative (to
i miuramine) antic ho linergic potencies .

The relativ e potency

ratios for serotonin , norepinephrine and dopamine, r eferred
to as t h e biogenic a.n ine ratios, can be comnared wit h one
another but t h e antic h olinergic:biogeni c ami ne ratios, in
t he last three columns of table 10, cann ot be compared
directly with t h e bio g enic amine ratios simpl y because a
different response measure was used i n determining t he
antic holinergic influence.

The values obtai ned for the

anticholiner gic:biog enic amine ratios become more meani ngful
when viewed as a percent of t h e total a ntic h olinergi c influence wit h resuect to each of t h e bi ogenic a mines.

~he

values

placed within parentheses directly below the anticholinergic:
biogeni c a.mine ratios were obtained by summing the t hr ee
ratios for a single drug and expressing each ratio as a
percent of t h e total.
Several portions of this table

demonstrate interesting

correlations with lmown effects of tric yclics.

Based upon

the biogenic amine comparisons in the first three columns to
t h e ri ght of t h e double line, t here appears to be n o diff erence between the effects of amitriptyline an d doxepin.
Clinical studies do not demonstrate any clear differenc e s
between doxepin and amitriptyline as antidepressants (Beck ,
1973).

Doxepin has been reported to be well tolerated by
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older patients because of fewer incidences of anticholinergic side effects .

This difference is clearly reflected in

the potencies of anticholinergic effects where amitriptyline
is ten times more uotent than doxepin.

This may sugg est

that the anticholinergic properties are not i mp ortant for
t he clinical therapeutic effect .

Cairncross et al . (1 963 )

sugg ested t hat the a."'1.ticholinergic effect was imuortant for
therapeutic activity but :B lac kwell
that the

antic ~ oliner g ic

~al .

(1972) conclud ed

effect was related more to the

sedative properties of the drugs .

This is difficult to

reconcile since stimulation of locomotor activity , a
behavioral resuonse measure which could be vie·wed as an
inverse indicator of sedation , has been s hown to be centrally
mediated by anticholinergic drugs (Aquilo:'.li us et a.l. , 1972) .
It may be that the difference in antic holiner gi c potency is
only reflected in the periphery with these two drugs .

The

particular proportional indluences upon the biogenic amine
syste:ns may serve to mask any psychostimulatory properties
these drugs possess if they were purely anticholinergic .
This may occur as a result of the lack of proportional
influences within the periphery that these neurotransmitter
systems may possess within the central nervous system .
look at the anticholinergic: biogenic amine ratio
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A

perc ent"

figures of table 10 sugg ests that there are no differences
in the relative effects of a.Dticholinergic to biogenic
amine influences between amitriptyline and doxepin.

It

may be as a. result of this balancing influence that doxeuin
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and aoitriptyline are sedative.
On the other end of the pharmacological suectrum is
the psychostimulatory effects of protriptyline.

Protr ip-

tyline is the only tricyclic antidepressant recommended by
a manufacturer for use in anergic :patients .

Since dopamin-

ergic influences are believed to be responsible for
stimulating effects on locomotor activity (?ibiger et al.,
1973; Creese and Iversen , 1973; 1975;

~seug

and Loh , 1974;

Tseug et al., 1974) and cholinergic -dopaminergic interactions are important as well (Klawans, 1968 ; Hornykiewicz ,
1966; Friehoff & Alpert , 1973) , it seems reasonable to conclude that a cho linergic -dopaminergic interaction ma.y
mediate the psychostimulatory effect of this drug .

Compared

with desmethylimipramine, the percent of anticholinergic dopa.minergic interaction is 22 times greater for protriptyline whereas the effects with respect to anticholinergicnorepinephrine or anticholinergic-serotonin influences are
norepinephrine or a.nticholinergic-serotonin influences are
comparable.

This may reflect the mechanism of psy chostimu

lation occuring in-vivo.
This approach may offer a reasonable, although
admittedly speculative, interpretation for the different
effects observed with the clinical use of tricyclics, but
most important is the therapeutic effect.

Review of the

relative potency ratios for biogenic amines demonstrates
the common factors which may suggest how all these drugs
ma.y work with respect to the neurotransmitters studied.

All
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dopamine:norepinephrine ratios a.re greater t han one and all
serotonin : dopamine ratios are less than one.

Con sidering

only the b iog enic amines, t h is is t h e onl y factor common
to all tricy clics reflected in table 10 .

It may b e sugg ested

t hat t h e relative effects of serotonin with respect to
dopaoine and norepinephrine with respect to DA are involved
.i n the antidepressant effect of t h ese drugs .
Cont inuing with t h e concept t hat a balance of effects
upon critical neurotransmitters may be responsible for the
t h erapeutic effect , t h ese observations are remi n isent of
t he elements of the "permissive hy pot he sis of depressionP
(Prang e et al ., 1974) .

This hy pot he sis stat es that s ero-

tonin acts as a gating or controlling influen ce for the
expression of either man ia or depression by :ncreased or
decreased levels of norepinephrine , respectively .

Agents

af f ecting t h ese systems perhaps with res pe ct to a third
buffer or reference system such as t he dopaminergic system
may account for t h e comm on di mension requir ed for a unified
neurotransmitter hypothesis of affective disorders .
An attempt to explain t h e mechanism of action of t h ese
drugs using only four of possibly scores of neurotran s mitters
is admittedly premature .

Certainly oth er me chanisms may

be responsible for the t herapeutic effect both within as
well as outside the frame work of the biogenic amine
hypothesis.
It is i mp ortant to nore that t h e develo pm ent of the
tricy clics came out of investi gations with anti histaminic

114

drugs are tricyclics possess

antihista~inic

properties .

Research directed towards evaluating these properties may
reflect more light on even more complex interactions then
we dare to expect.

Knowledge of the role of neurotrans-

mitters in behavior is still at its infancy (Ealdessarini,
1975).

Unt il more data is accu:nula.ted with respect to the

pharmacokinetics , physical properties and phar::na.codynamics
of tricyclic antidepressants, table like that of table 10
represent a way in which leads toward a particular line of
investigation may be obtained.

A glimmer of hope in unrav-

elling the complex interactions of a number of variables in
biological systems is the increasing applications of statistical methods.

Techniques of utilizing parametric and non-

parametric statistical methods are becoming more accessible
and easier to apply.

Pattern recognition

tecrL~iques

are

available to a.id in the analysis of complex interactions
using cluster analysis, path analysis, principal components
and other multivariate approac h es (Rarper, et

c.

a~,

1977).

Conclusion
Should the limitations noted above prove to be n eglie -

i b le, t hen it would appear that protript:rline bl ocks t h e
uptake of norepinephrine up on chronic adoinistration whereas
when administered sub-acutely uptake blockade is not clearly
discernable .

These findings demonstrate a

te~poral

corre-

lation of untake blockade with clinical effectiveness in
humans and lends support to both t he catecho lamine hypo t hesis
and the propo sed mechanism of action of tricyclics as uptake
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blockers .

In addition it is i n teresting to note that there

is a ris k of attemp ted suicide in deuressives during t he
initial days of ch emotherapy (Beck , 1973) and sub- acute
admi n istration displays hi ghl y variable effects and per haps
even some potentiation of uptake t h ereby enhancing t h e
functional depletion of neurotransnitter at the level of
the uost synaptic receptors .

This effect could exulain t he

clinical observation of increased suicidal tenden cy during
initiation of tri cyclic chemotherapy .
In support of the sub- acute data obtained is the evi dence that twelve hours post- protr iptyline using either
serotonin or tryptarnine as substrate , MAO activity is elevated ( Ed Kaiser- pers onal c ommunication) .
uptake provides more substrate for

r~AO

An increase in

t herefore t he se

results appear c orroborative of the subacute data presented
here .
It appears that the relative antic h olinergic properties
can be predictive of the psych ostimulatory effects of pr otriptyline .

Comparisons of the effects of drugs using

in- vitro biochemical techniques may be useful in formulating
hypotheses regarding the mechanism of action of the tricyclic
antidepressants .

The lack of psychostimulatory action of

the most potent anticholinergic of the tricy clics, ami triptyline , may be explained by a relative interaction
between antic holinergic and dopaminergic influences .

11 6

CHAPTER V:

REFERENCES

Adamic. S.:
phragm

Accumulation of acetylcholine by the rat diaBiochem. Pharmacol. 12.:2445-2451,1970.

Aghajanian, G.K., 3loom, F.E., Lovell, R.A., Sheard, M. H. &
Freedman, D.X.: The uptake of 5-hydroxytryptamine-H3
from the cerebral ventricles: An autoradiographic
localization. Biochem. Pharmacol . 12.:1401-1403,1966.
Alexanderson, B., Asberg, M. & Tuck, D.: Relationship between the steady-state plasma concentration of nortriptyline and some of its pharmacological effects.
In Bi ological Effects of Drugs in Relation to Their
Plasma Concentration Davies, D.S. & ~ric hard, 3 . N. C.
(eds.) British Pharmacological Society, University
Park Press, :S altimore, Md. 191-199, 1973.
Anden, 'J .-E., Dahlstrom , A., Larsson, K., Ols on , L. &
Ungerstedt, U.: Ascending monoamine neurons to the
telencephalon and diencephalon. Acta Fhysiol . Scand.
67:313-326,1966.
Aquilonius, S.M., Lundholm, B. & Winbladh, B.: Effects of
some anticholinergic drugs on cortical acetylcholine
release and motor activity in rats. Europ. J. Pharmacol. 20:224-230,1972.
Arregui, A., Logan, W.J., Bennett , J.P. & Snyder, S. H.:
Specific glycine-accumulating synaptosomes in the
spinal cord of rats. Proc. Nat. Acad. Sci. 69 :3485 3489, 1972.
Asberg, M., Cronholm, B. Sjoqvist, F . & Tuck, D.: The
correlation of subjective side-effects with plasma
concentrations of nortriptyline. Brit . ~ ed. J. ±:
18-21,1970.
Asberg, M., Cronholm, B., Sjoqvist, F. & Tuck , D.: Relationship between plasma level and therapeutic effect
of nortriptyline. Brit. Med. J. }:331-334,1971.
Avakian, O.V. & Gillespie, J.S.: Uptake of noradrenaline
by adrenergic nerves, smooth muscle and connective
tissue in isolated perfused arteries and its correlation with vasoconstrictor response. Brit . J. ?harmacol.
Chemother. 32:168-184,1968.
Axelrod, J.: 0-Methylation of epinephrine and other catechols in-vitro and in-vivo. Science 126:400-401,1957.
Axelrod, J.: Metabolism of epinephrine and other sympathomimetic amines. Physiol. Rev. 39:751-776,1959.
/

Axelrod, J., Hertting , G. & Patrick, R.W.: Inhibition of
H3-norepinephrine release by monoamine oxidase inhib-

118
itors.

J. Pharmacol. 134:325-328,1961a.

Axelrod, J., Hertting , G. & Potter, L.T.: Effect of drugs
on the uptake and release of H3 -norepinephrine in the
rat heart. Nature 194:297,1962.
Axelrod, J. & Tomchick, R.: Increased rate of metabolism
of epinephrine and norepinephrine by sympathomimetic
amines. J. Pharmacol. 130:367,1960.
Axelrod, J., Weil-Malherbe, H. and Tomchick, R.: The physiological disposition of tt3 -epinephrine and its metabolite metanephrine. J. Pharmacol. Exp. Ther. 127:251-256,
1959.
Axelrod, J., Whitby, L.G. and Hertting, G.: Effect of
psychotropic drugs on the uptake of H3-norepinephrine
by tissues. Science 133:383-384,1961b.
Bacq, Z. M., Goss elin, L., Dresse, A. & Rensen , J.: Inhibition of 0-methyltransferase by catechol and sensitization to epinephrine. Science 130:453-454,1959.
Balcar, V.J. & Johnston, G.A.R.: Glutamate uptake by brain
slices and its relation to the depolarization of
neurons by acidic amino acids. J. Neurobiol. 3:295301,1972a.
Balcar, V.J. & Johnston, G.A.R .: The structural specificity of the high affinity uptake of 1-glutamate and
1-aspartate by rat brain slices. J . J euroch em. _12:
2657-2666,1972b.
Balcar, V.J. & Johnston, G.A . R.: High affinity uptake of
neurotransmitters: Studies on the uptake of 1-aspartate, GABA, 1-glutamate and glycine in cat spinal cord.
J. Neurochem . 20:529-539,1973.
Baldessarini , R.J.: Biogenic amine hypothesis of affective
disorders. In The Nature and Treatment of Depression
Flack, F . F . & iSraghi, S.C. (eds.) ·/ lliley & Sons, Inc.
New York . 347-385,1975.
Balzer , H. & Holtz, P.: Beeinflussung der wirkung biogener
amine durch hemmung der aminoxydase. Arch . Exp . Path .
Pharmakol. 227:547-558,1956.
Beck , A.T .: The Diagnosis and Tv'. anagement of Depression
University of Pennsylvania Press, Phila. 81 -122,19 73.
Bennett , J.P., Logan, W.J . & Snyder, S.H .: Amino acid
neurotransmitter candidates: Sodium dependent highaffinity uptake by unique synaptosomal fractions.
Science 178:997-999,1972.

Bickel, M.H.: Metabolism and structure-activity relationships of thymoleptic drugs. In Antidenressant Drugs
Garattini, S. & Dukes, M. N.G. (eds.) Excerpta Medica
Foundation, International Congress Series No. 122.
3-9,1966.
Blackwell, B. Lipkin, J.O., ,1eyer, J. H., Kuzma , R. &
Boult er, W.V.: Dose responses and relationships between anticholinergic activity and mood with tri.
cyclic antidepressants. Psychopharmacol. 25:205-217,
1972.
Blaustein , M. P. , Johnson, E. M. & ~ eedleman, P .: Calciumdependent norepinephrine release from pre-synaptic
nerve endings in-vitro. Proc. Nat. Acad . Sci. 69 :
2237-2240,1972.
Bloom, F.E. & Iversen, L.L.: Localizing 3H-GABA in nerve
terminals of rat cerebral cortex by electron microscopic autoradiography. Nature 229:628-630,1971.
Bogdanski, D.F. and Tissari, A.: Sodium dependent uptake
and storage of amines in synaptosomes. Pharmacologist
_2:250,1967.
Bogdanski, D.F., Tissari, A.H. & Brodie, B. B.: Role of
sodium, potassium, ouabain and reserpine in uptake,
storage and metabolism of biogenic amines in synaptosomes. Life Sci. ]:419-428,1968.
Borga, O., Azarnoff, D.L., Plym Forshell, G. & Sjoqvist, F .:
Plasma protein binding of tricyclic antidepressants in
man . Biochem . Pharmacol. 18:2135-2143,19 69.
3radford, H. F.: Isolated nerve terminals as an in-vitro
preparation for the study of dynamic aspects of
transmitter metabolism and release. In Handb ook of
Psychopharmacolog;l Plenum Press, New York
Iversen, ~.L., Iversen, S.D. and Snyder , S. E .
1:191-252,1975.
Brodie, B. B. & Beaven, M.A .: Neurochemical transducer
systems. Med. Exp. 8:320-351,1963.
Brown , G.L.: The Croonian Lecture 1964: The release and
fate of the transmitter liberated by adrenergic
nerves. Proc. Roy . Soc. Biol. 162 :1-19,1965.
Burgen , A.S.V. & Iversen, L.L.: The inhibition of noradrenaline uptake by sympathomimetic amines in the
rat isolated heart . Brit . J. Pharmacol . Ch emother.
25:34-49,1965.
Burn , J. H.:

The action of tyramine and ephedrine.

120
J. Pharmacol . Exp. Ther . 46:75-95,1932.
3urn , J.H.: The mechanism of the action of chemical substrates at nerve endings and the part played by peripheral ganglia . Acta Phys iol. Scand. 29:40-49,1953.
Burnstock, G., McClean, J .R. & ~/right, M. : Noradrenaline
uptake by non-innervated smooth muscle . Brit . J.
Pharmacol. 43:180-189,1971.
Burton, R. M.: Gangliosides and acetylcholine of the central
nervous system III. The binding of radioactive acetylcholine by subcellular particles of the brain. Int.
J. Neuropharmacol. l:13-21,1964.
Cairncross, K.D ; , Gershon, S. & Gust, I.D.: Some aspects of
the mode of action of imipramine. J. Neuropsychiatr.
4:224-231,1963.
Carlsson, A., Hillarp, N.A. & Waldeck , B .: Analysis of the
Mg++-ATP-dependent storage mechanisms in the amine
granules of the adrenal medulla. Acta Phys iol. Scand.
59Suppl.215,1963.
Chirigos, FI .A., Greengard, P. & Udenfriend , S.: Uptake of
tyrosine by rat brain in-vitro. J. Biol . Chem. 235:
2075-2079,1960.
Clarke, D.E., Jones, C.J. & Linley, P.A .: Histochemical
flourescence studies on noradrenaline accumulation by
uptake 2 in the isolated rat heart. Brit . J. Pharmacol .
37:1-9,1969.
Cleland, W. W.: The statistical analysis of enzyme kinetic
data. Advan. Enzymol. 29:1-32,1967.
Cohen, S.R. and Lajtha, A.: Amino acid transport. In
~andbook of N eurochemistr~ Lajtha, A. (ed.)
Plenum Pr ess, New York 7: 43-572,1972.
Colburn, R.W., Go odwin, F.K., Murphy, D.L., 3unney, W.E. &
Davis, J.M.: Quantitative studues of norepinephrine
uptake by synaptosomes. Bi ochem. Pharmacol . 17:957964, 1968.
Cooper, J.R., Bl oom, F .E. & Roth , R.H .: Biochemical 3asi s
.9,f Neuro~harmacology Second Edition; Oxford Press
p.126,19 4.
Corne , S.J. & Graham , J . D. P .: The effect of inhi~ition of
aoine oxidase in-vivo on administered adrenaline,
noradrenaline, tyramine and serotonin. J. Physiol .
135:339-349,1957.

121
Cornish-3 owden, A. & Eisenthal, R.: Statistical considerations in the estimation of enzyme kinetic parameters by
the direct linear plot and other methods . Biochern . J .
139:721-730,1974.
Costa , E.: Turnover rate of neuronal monoamines : pharmacological implications. In The Present Status of
Psychotr ouic DruBs: Proceedings of the International
Congress of the olleBium Internationale Neuronsych-nharmacolo~ium erletti, C. & Bove, ?.J.
Ecerp"ta Medicaoundation, Amsterdam. 11 -35, 1969.
Costa, E. & Meek, J.L.: Regulation of biosynthesis of
catecholamines and serotonin in the CNS. Ann. Rev .
Pharrnacol. 1!:491-511,1974.
Coyle, J.T. & Snyder, S. H.: Catecholamine uptake by synaptosorne s in homogenates of rat brain: Stereospecificity
in different areas. J. Pharrnacol. Exp. Ther . 170:221231,1969.
~
Creese, I. & Iversen, S.D.: Blockade of amphetamine induced
motor stimulation and stereotypy in the adult following neonatal treatment with 6-hydroxydoparnine .
Brain Res. 2.2.:369-382,1973.
Creese, I. & Iversen, S.D.: The pharmacological and
anatomical substrates of the amphetamine response in
the rat. Brain Res . 83:419-436,1975.
Davis, J. M.: Theories of biological etiology of affective
disorders. Int. Rev. Neurobiol • .11_:145-175,1970.
Davis, J. M., Goodwin, F . K., Bunney, W.E. Jr ., _viurphy, D.L.
& Colburn, R. W.: Effects of ions on uptake of norepinephrine by synaptosornes. Pharmacologist 2:184,1967.
Dengler, H.J.: Effects of drugs on monoamine uptake in
isolated tissue. In Proceedings of the Second International PharmacoloR Meeting. Prague ,1963 Koelle, G. B•
.Douglas, W.W. & Car sson, A. Pergamon Press, Oxford .
l:261-275, 1965.
Dengler, H.J., Michaelson, I.A., Spiegel, H.E. & Titus, E.:
Int. J. Neur opharmacol. 1:23-38,19 62.
Dengler, H.J., Spiegel, H.E. & Titus , E. O.: Effects of
drugs on uptake of isotopic norepinephrine by cat
tissues. Nature 191:816-817,1961.
Dowd, J.E. & Riggs , D.S.: A comparison of estimates of
Michaelis-I": enten kinetic constants from various linear
transformations. J . 3iol . Chern. 240:863-869,1965.
Dowdall, M.J. and Simon, E.J.:

Comparative studies on

synaptosomes: Uptake of (N- r·::e-E3) ch oline by synaptosomes from squid optic lobes. J . Neurochem. £1.:9 69982,1973.
Draskoczy, P . R. & Trendelenburg , U.: Intra-neuronal and
extra-neuron~l sympathomimetic amines in the isolated
nictitating membrane of the cat. J. Pharmacol . Exp .
Ther. 174:290-306,1970.
Edwards, D. J. & Burns , Iv'I . 0 . : Effects of tricyclic antidepressants upon huma..~ platelet monoamine oxidase.
Life Sci • .12.:2045-2058,1974.
Ehinger, B.: Cellular location of the uptake of some
amino acids into the rabbit retina. Brain ae s.
46:297-311,1972.
Ehinger, B. & Sporrong, B.: Neural and extra-neural localization of noradrenaline in the rat heart after perfusion at high concentration. Experientia 24:265-266,
1968.
Eisenthal, R. & Cornish-Bowden, A.: The direct linear plot:
A new graphical procedure for estimating kinetic parameters. Biochem. J. 139:715-720,1974.
Elliot, K.A.C. & Henderson , J .: Factors affecting acetylcholine found in excised brain. Amer . J . Phy siol.
165:364-374,1951.
Elmore, D.T., King ston, A.E. & Shields, D. 3 .: The computation of velocities and kinetic consta..~ts of reactions,
with particular reference to enzyme-catalysed processes. J. Chem. Soc. Pt .2:2070- 2078 ,19 63 .
Euler, U.S. von & Lishajko, F.: Uptake of L- and D- isomers
of catecholamines in adrenergic nerve granules .
Acta Physiol. Scand. 60 :217-222,19 64 .
Farnebo, L.O. & Malmfors, T.: Hist ochemical studies on the
uptake of noradrenaline and alpha-methylnoradrenaline
in the perfused rat heart. Europ. J. Pharmacol. 2:
313-320,1969.
Fibiger, H.C., Fibiger, H. P . & Zis, A. P .: Attenuation of
amphetamine induced motor stimulation and stereotypy
by 6-hydroxydopamine in the rat. Brit . J . Pharmacol .
47:683-692,1973.
Finney, D.J.: Probit Analysis Third Edition Cambridge
University Press, London 8-17,1971.
Fischer, J.E., Kopin , I.J. and Wurtman, R.L.: Effects of
lumbar sympathectomy on the uterine uptake of catechol-

123
amines.

Nature 203:938-939,1964.

Friedhoff , A.J. & Alpert, ~ .: A dopaminergic-ch olinergic
mechani sm in the production of psyc~otic symptoms.
Biol. Psychiatr. §:1 65-1 69,1973.
Fuxe , K. & Ungerstedt, U.: Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular
injection. J. Pharm. Pharmac ol • .12:335-337,1967.
Giese, J., Ruther, E. & Matussek, N.: Quantitative estimation of H3-norepinephrine and its metabolites by thinlayer chromatography . Life Sci. §:1975-1982 ,1967.
Gillespie, J.S.: The role of receptors in adrenergic
uptake. In !drener ~ ic Neurotransmission '.'/olstenholme ,
G . E . tl . & O' Connor , ,. • (eds.) Ciba Foundation Study
Group 3 o. 33. Churchill, London . 61-72,19 68 .
Gillespie, J.S.: Uptake of noradrenaline by smooth muscle.
Brit. Med. Bull . 29:136-141,1973.
Gillespie, J.S., Hamilton, D. N. H. & Hosie, R.J. A.: The
extraneuronal uptake and localization of noradrenaline
in the cat spleen and the effect on this of some drugs
of cold and of denervation. J. Physiol. 20 6 :563-590,
1970.
~
Gillespie, J.S. & Towart, R.: Uptake kinetics and ion requirements for extraneuronal uptake of noradrenaline
by arterial smooth muscle and collagen. Brit. J.
Pharmacol . 47:566-567,1973.
Glassman, A. H., Hurwic, M.J. & Perel, J . M.: Plasma binding
of imipramine and clinical outcome. Amer. J. Psychiatr.
130:1367-1369,1973.
Glassman, A.H., Perel, J. M., Shostak, M., Kantor , S.J. &
Fleiss, J.L.: Clinical implications of imipramine
plasma levels for depressive illness. Arch. Gen .
Psychiatr. 34:197-204,1977.
Glick, N. B. : Inhibitors of transport reactions. A. Inhibitors of ATP-ase: NaK-ATPase and related enzymic
activities. In Metabolic Inhibitors Rochester, R . M.,
Kates , M. & Quas-:Cel, J.H. (eds.) Academic Press, New
York . 2:1-45,1972.
Glowinsky, J. & Iversen, L.L.: Regional studies of catechol
amines in the rat brain. J. Neurochem • .11.:655-669,
1966.
Goldstein , A.: Biostatistics: An Introductory Text

MacMillan Co., New York. p.154,1967.
Goodlet, I., Mireylees, S.E. & Sugrue, M. F .: Effect s of
mianserin, a new antidepressant, on the in-vitro and
in-vivo uptake of monoamines. Brit. J. Pharmacol •
.§.1.:307-313,1977.
Graefe, K.-H.: Methodology of catecholamine transport
studies: Definition of terms. In The Mechanism of
Neuronal and Extraneuronal Trans ort of Catecholamines
orK.

,1

o.

Grahame-Smith, D.G. & Parfitt , A. H.: Tryptophan transport
across the synaptosomal membrane. J. Neurochem. 11=
1339-1353,1970.
Gray, E.G. & Whitt aker, V.P.: The isolation of nerve
endings from brain: An electron-microscopic study of
cell fragments derived by homogenization and centrifugation. J. Anat • .2.§.:79-88,1962.
Guroff, G., King , W. and Udenfriend , s.: The uptake of
tyrosine by rat brain in-vitro. J. Biol . Chem. 236:
1773-1777, 1961.
Guth, P .S.: Effect of phenothiazines on neurohumor-containing particles from mammalian brai::.1. Fed . Proc .
(Arner. Soc. Exp. Biol .) £1_:1100-1102,1962.
Haga , T. & Noda, H.: Choline uptake systems of rat brain
synaptosomes. Bi ochim . Biophys. Acta 291:564-575,1973.
Hamberger , B.: Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. Acta Psysiol .
Scand. 71Suppl.295:7-55,1967.
Hamberger , B., Malmfors, T., Norberg, K. A. and Sachs , c.:
Uptake a~d accumulation of catecholamines in peripheral
adrenergic neurons of reserpinized animals, studied
with a histochemical method. Biochem. Pharmacol. 13:
841-844,1964.
~
Hamberger , B. & Masuoka, D.: Localization of catecholamine
uptake in rat brain slice. Acta Pharmacol . Toxi col.
2 2 : 3 63-3 68 , 19 65 •
Hammer , W., Idestrom, C.M. & Sjoqvist, F.: Clinical
control of antidepressant drug therapy. In Ant idepress-·
ant Drugs Garattini, S. & Dukes, M·. N. G. (eds.)
~cerpta Medica Foundation, International Congress
Series No. 122. 301-310,1966.
Harper, A. M., Duewer, D.L., Kowalski, B. R. & Fasching, J .L.:
ARTHUR and experimental data analysis: The use of poly-

125

Harris, J.E. & Baldessarini, R.J.: Th e uptake of H3dopamine by homogenates of rat corpus striatum:
Effects of cations. Life Sci. Jl.:303-312,1973.
Heilbronn, E.: The effect of phospholipases on the uptake
of atropine and acetylcholine by slices of mouse brain
cortex. J. Neurochem. 16:627-635,1969.
Hemsworth, B.A. & Bosman, H. 3 .: The incorporation of triethylcholine into isolated guinea pig cerebral cortex
synaptosomal and synapti c vesicle fraction. Europ .
J. ~harmacol. 1..§.:1 64-170,1971.
Hendley, E.D. & Snyder, S.H.: Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
Nature 220:1330-1331,1968.
Hertting, G., Potter, L.T. & l1.JCelr od, J.: Effect of decentralization and ganglionic blocking agents on the
spontaneous and reserpine induced release of E3-norepinepbrine. J. Pharmacol. 136:289-292,1962.
Hodgkin, A.L. & !lartin, K.: Choline uptake by giant axons
: of Loligo. J. Phy siol. 179:26-27,1965.
Hokfelt, T., Jonsson, G. & Lidbrink, P .: Ele ctron microscopic identification of nerve ending particles in rat brain
homogenates. Brain Res. 22:147-151,1970.
Horn, A.S.: Structure-activity relations for the inhibition
of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain
homogenates. Brit. J. Pharmacol. 47:332-338,1973.
Hornykiewicz, O.: Dopamine (3-hydroxytryptamine) and brain
fu..~ction.
Pharm. Rev • .1§.:925-964,1966.
Hosli, L. & Hosli, E.: Autoradiographic localization of the
uptake of glycine in cultures of rat medulla oblongata.
Brain Re s. 45:612-616,1972.
Hunt , P., Kannengiesser, M- E. & Raynaud , J-P.: Nomifensine:
A new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J. Phar m.
Pharmacol. 26:370-371,1974.
Inch, T.D., Green , D. M. & Thomps on, P . 3 .J.: J . Pharm .
Pharmacol. 25:359,1973.

Iversen, L.L.: The inhibition of noradrenaline uptake by
drugs. Advan. Drug Res. ~:5-46,j965.
Iversen, L.L.: The uptake of adrenaline by the rat isolated
heart. Brit. J. Pharmacol. 24:387-394,1965a
Iversen, L.L.: The uptake of catecholeamines at high perfusion concentrations in the rat isolated heart: A
novel catecholeamine uptake process. Brit. J. Pharmacol •
.2_:18-33,1965b.
Iversen, L.L.: Role of transmitter uptake mechanisms in
synaptic neurotransmission. Brit. J. Pharmacol. 41:
571-591,1971.
Iversen, L.L.: Methods involved in studies of the uptake of
biogenic amines. In Methods in Ivesti~ati ve a.."ld
Diagnostic Endocrinologl Berson, s.A.ed.) NorthHolland ~ublishing Co. msterdam !:569-603,1972.
Iversen, L.L.:

Uptake process for biogenic amines. In
H andboo~ of Psychopharmacolo~ Iversen, L.L., Iversen,
S.D. & ~nyaer, S.H. (eds.)}. 81-442,1975.
Iversen, L.L. ·& Bloom, F.E.: Studies of the uptake of n3Gl\..BA and H3 -glycine in slices and homogenates of rat
brain and spinal cord by electron microscopic autoradiography. Brain Res. 41:131-143,1972.
Iversen, L.L., Glowinski, J. & Axelrod, J.: The physiological disposition and metabolism of norepinephrine in
immunosympathectomized animals. J. Pharmacol. Exp.
Ther. 151:273-284,1966.
Iversen, L.L. &·Johnston, G.A.R.: GAB A uptake in rat central
nervous system: Comparison of uptake in slices and
homogenates and the effects of some inhibitors.
J. Neurochem • ..1l?,:1939-1950,1971.
Iversen, L.L. & Neal, M.J.: The uptake of H:3-GABA by slices
of rat cerebral cortex. J. Neurochem. 12.:1141-1149,
1968.
Iversen, L.L. & Salt, P.J.: Inhibition of the extra-neuronal uptake of catecholamine in the isolated rat h eart
by cholesterol. Nature New Biol. 238:91-92,1972.
Iversen, L.L. & Snyder, S. H.: Synaptosomes: Different populations storing catecholamines and gamma-aminobutyric
acid in homogenates of rat brain. Nature 220:796-798;
1968.
~
Jacobowitz, D.

&

Brus, R.:

A study of the extraneuronal

127
uptake of norepinephrine in the perfused heart of the
guinea pig. :surop. J. ?harmacol. 12.:274-284,1971.
Jacobsen, E.: The theoretical basis of the chemotherapy of
depression. In Depression: Proceedinas of the S. mposium held at Cambridge , 22 to 2o . et • 195
ted.) Cambridge Univ. Press 268,19 4.
Janowsky, D.S., El-Yousef, M. K., Davis, J. M. & Sekerke, H.G.:
A cholinergic-adrenergic hypothesis of mania and
depression. Lancet ii:632-635,1972.
Johnston, G.A. R. & Iversen, L.L.: Glycine uptake in rat
central nervous system slices and homogenates:
Evidence for different uptake systems in spinal cord
and cerepral cortex. J. Neurochem • ..1.§.:1951-1961,1971.
Kai ser, Ed .: Pers onal Communication. Research Associate ,
Dept. Endocrinology, Rhode Island Hospital . Unpublished
Doctoral Dissertation research.
Kamijo, K., Koelle , G.B. & ','/agner, H. H.: Modification of
the effects of sympathomimetic amines and of adrenergic
nerve stimulation by l-isonicotinyl-2-isopropylhydrazine
(IIH) and isonicotinic acid hydrazide (INH ).
J. Pharmacol . 117:213-227,1955.
Kant, G.J. & Meyerhoff, J.L.: Release of endogenous norepinephrine from rat hypothalamus in-vitro. Life
Sci. 20:149-154,1977.
Katz, B. & Miledi, R.: The binding of acetylch oline to
receptors and its removal from the synaptic cleft.
J. Physiol. 231:549-574,1973.
Katz, H.S., Salehmoghaddum, S. & Collier, B.: The accumulation of radioactive acetylcholine by a syfilpathetic
ganglion and by brain : Failure to label endogenous
stores. J. reurochem. 20:569-579,1973.
Katz, R.I. & Chase , T. N.: Neurohumoral mechanisms in th€
brain slice. Advan . Pharmac . Chemother. §:1 -3 0 , 1970 .
Kirshner , N.: Uptake of catecholamines by a particulate
fraction of the adrenal medulla. J . 3iol . Chem .
237:2311-2317,1962.
Klawans, H. L .: The pharmacology of Parkinsonism . Dis .
Syst. 29:805-816,1968.

Terv.

Koelle, G. B. & Valk , A.: Physiological implications of the
histochemical localization of monoamine oxfdase. J .
Physiol . 126:434-4 47 ,195 4.

128
Kopin , I.J., Gordon , E. K. & Horst, D.: Determinants of
tissue uptake of norepinephrine. Fed . Proc . (Amer.
Soc . Exp . Biol.) 23:349,1964.
Kuhar, M. J.• : Neurotransmi tt er uptake: A tool in identifying neurotransmitter specific pathways. Life Sci .
12.:1623-1634,1973.
Kuhar, M.J., Aghajanian , G. K. & Roth, R. H.: Serotonin
neurons: A synaptic mechanism for the reupt~ke of
serotonin. In Advances in Biochemical Ps. chouharmacolEEJ_ Raven Press , l' ew ork.
1_: 8 - 9 , 197 4 .
Kuhar , M.J., Green , A.I., Snyder , S. H. & Gfeller , E.: Separation of synaptosomes storing catecholamines and
gamma-aminobutyric acid in rat corpus striatum.
Brain Res. 21:405-417,1970.
Kuhar, M. J. , Roth, R.H. & Aghajanian, G. K. : Synapt osomes
from forebrains of rats with mid brain ranhe lesions:
Selective reduction of serotonin uptake . J . Pharmacol .
Exp . Ther . 181:36-45,1972.
Kuhar, M.J., Sethy, V.H., Roth , :t.H. & Aghajanian, G. K.:
Choline: Selective accumulation by central cholinergic
neurons. J. Neurochem. 20:581-593,1973.
Kuriyama , K., Wein stein, H. & Roberts, E. : Uptake of gammaaminobutyric acid by mitochondrial and synaptosornal
fractions from mouse brain. Brain Res. 16:479-492,
1969.
Laduron, P.: Tissue fractionation in neurobiochemistry: An
analytical tool or a source of artifacts . Int . ~ ev.
Neurobiol. 251-281,1977.
Lane, J.D. & Aprison, M. H.: Calcium- dependent release of
endogenous serotonin, dopamine and norepinephrine from
nerve endings. Life Sci. 20:665- 672,1977.
Langer, S.Z .: The metabolism of H3-noradrenaline released
by electrical stimulation from the isolated nictitating
membrane of the cat and from the vas deferens of the
rat. J. Physiol. 208:515-546,1970.
Lapin, I. P . & Oxenkrug, G.F.: Intensification of the central
serotoninergic processes as a possible determinant of
the thymoleptic effect . Lancet 1:132-13 6 ,1969.
Leonard, B . E.: _reuroch emical and neuroph2rrnacolo gical aspects of depression. Int. ~ev. iJeurobiol • .1§.:357-387,
1975.
Levi, G. & Raiteri, M.:

Detectability of high and low

129
affinity uptake systems for GABA and glutamate in rat
brain slices and synaptosomes. Life Sci . 1£:81-88,
1973a.
Levi , G. & Raiteri , M.: GABA and glutamate uptake by subcellular fractions enriched in synaptosames: Critical
evaluation of some methodological aspects . Brain Res .
165-185,1973b.
Levi, G. and Raiteri, M.: Synaptosomal transport processes .
Int. Rev. Neurobiol. 51-74,1976.
Lew, G. M. & Quay , W. 3 .: Twenty four hour rhythmic uptake of
H3 -norepinephrine in vitro by hypothalamus and medial
lower brainstem. Int. J. Chronobiol. ~:209-213,1974.
Liang, c.c. & Quastel, J.H.: Uptake of acetylcholine in rat
brain cortex slices. Biochem . Pharmacol. 18:1169-1185,
1969.
Lidbrink, P. & Jonsson, G.: Noradrenaline nerve terminals
in the cerebral cortex: Effects on noradrenaline uptake
and storage following axonal lesion with 6- hydroxydopamine. J. Neuro chem . ll:617-626, 1974.
Lightman, s. & Iversen, L.L.: Role of uptake 2 in the extraneuronal uptake and metabolism of catecholamines in the
isolated rat heart . Brit . J. Pharmacol . 37:638- 649,1969 .
Lindmar, R. & Muscholl , D.: Die wirkung von pharmaka auf
die elimination von noradrenalin aus der perfusions
flussigkeit und die noradrenalin-aufnahme in das
isolierte herz. Arch . Exp. Path. Pharmakol. 247:
469-47 2,1964 .
~
Lineweaver, H. & Burk, D.: The determination of enzyme
dissociation constants. J . Amer. Chem. Soc. 56:
658-666,1934.
A. & Hokfelt ~ T.: Autoradiographic uptake patterns
of (JH) GABA and (JH) glycine in central nervous
tissue with special reference to the cat spinal cord.
Brain Res . 62 :587-595,19 73.

Ljungdahl~

Logan, W.J . & Snyder, S.H.: High affinity uptake systems for
glycine, glutamic acid and aspartic acid in synaptosomes of rat central nervous tissue. 3 rain Res.
42 : 413-431 ,19 72 .
Lowry, O. H., Rosebrough, N.J., Farr, A.L. & Randall, R. J .:
Protein measurement with t h e folin ph enol reag ent.
J . Biol. Chem. 193:265-275,1951.
't acmillan, W. R. :

A hypothesis concerning the effects of

130

cocaine on the action of sympathomimetic amines.
J. Pharmacol. 1!:385-391,1959.

Brit.

l'-iarchbanks, R . M.: Exchangeabili ty of radioactive acetylcholine of synaptosomes and synaptic vesicles.
Biochem. J. 106:87-95,1968a.
Marchbanks, R. M.: The uptake of (c 14 ) choline into synaptosomes in-vitro. Biochem. J. 110:533-541,1968b.
Marchbanks, R. M.: Biochemical organization of choliner gic
nerve terminals in the cerebral cortex. In Cellular
~namics of the l euron Barond es, S. H. (ed.) Academic
~ress, New York 115-135,1969.
Martell, A.E. & Sillen, L.G.: Stability Constants London
Chemical Society, 1964; and Suppl. 1, 1971.
Massari, V.J. and Sanders-Bush, E.: Synaptosomal uptake and
levels of serotonin in rat brain areas after parachloroamphetamine or B-9 lesions. Europ. J. Pharmacol •
.22.:419-422,1975.
··:Iatus, A.I. & Dennison, M.E.: An autoradiographic study of
uptake of exogenous glycine by vertebrate spinal cord
slices in-vitro. J. Neurocytol. 1:27-34,1972.
McClure, D. J. : The role of dopamine in depression.
Psychiatr. Assoc. J. 1§.:309-312,1973.

Can.

Mirkin, B.L., Giarman, N.J. and Freedman, D.X.: Uptake of
noradrenaline by subcellular particles in h omogenates
of rat brain. Bi ochem. Pharmacol. j_g:214-216,1963.
Muscettola, G., Goodwin, F. K., Potter, W.z., Claeys, M. M.
Markey, S.P.: Imipramine and desipramine in plasma
and spinal fluid. Arch. Gen. Psychiatr. 35:621-625,
1978.
~

&

Muscholl, E.: Die hemmung der noradrenalin-aufnahme des
herzens durch reserpin und die wirkung von tyramin.
Arch. Exp. Path. Pharmakol. 240:231-234,1960.
Muscholl, E.: Effect of cocaine and related drugs on the
uptake of noradrenaline by heart and spleen. Brit.
J. Pharmacol • .1§.:352-359,1961.
Neal, M.J.: The uptake of (c 14 ) glycine by slices of
mammalian spinal cord. J. Physiol . 215:103-117,1971.
Neame, K.D.: Phenylalanine as inhibitor of transport 01'
amino acids in brain. Nature 192:173-174,1961.
Neame, K.D.:

Uptake of histidine, histamine and other imida-

131
zole derivatives by brain slices. · J.
655 - 662 , 1964.

~f eurochem.

11:

Norberg, K- A. & Hamberger, B.: The sympathetic adrener gic
neuron. Acta Physiol . Scand. 63Suppl.238:5-42,19 64 .
S.R. C< Saar , ~ .: A histochemical study of noradrenaline in the guinea pig trachea. 3rit. J.
Pharmacol . 49 :2 67-278 ,1973.

O'Don~ell ,

Oswald, I., Brezinova, V. & Dunleavy, D. L.?.; On the slow~
ness of action of tricyclic antidepressant drugs.
Brit . J . Psychiatr. 120:673-677,1972.
Parfitt, A. & Grahame-Smith , D. G.: The transfer of tryptophan across the synaptosomal membrane . In Aromatic
Amino Acid in the Brain Ciba Foundation Symposium No. 22
Elsevier , New York 175-192,1974.
Peterson, N. A. & Rughupathy, E.: Developmental transitions
in uptake of amino acids by synaptosomal fractions
isolated from rat cerebral cortex. J. 'Jeurochem. 21 :
97-110,1973.
Phillis, J.W.: Minireview: The role of calcium in the central effects of biogenic amines. Life Sci . 1!:11891201, 1974.
Polak, R. L.: The influence of drugs on the uptake of acetylcholine by slices of cerebral rat cortex. Brit. J.
Pharmacol . 36:144-152,1969.
Polak , R .L., & fv: eeuws, M. !v! .: The influence of atropine on
the release and uptake of acetylcholine by the isolated
cerebral cortex of the rat. Biochem. Pharmacol. 15:
989-992, 1966.
Porter, W. R. & Trager , W.F.: Improved non- parametric
statistical methods for the estimation of MichaelisMent en kineti c parameters by the direct linear plot.
Biochem. J. 161:293-302,1977.
Potter, L.T.: Uptake of choline by nerve endings isolated
from rat cerebral cortex. In The Interactions of Drugs
and Subcellular Com1onents on Animal Cells Campoell,
P . N. (ed.) 293-364, 968.
Potter, L.T. & Axelrod, J .: Intracellular localization of
catecholamines in tissues of the rat. Nature 194:
581-582,1962.
Potter , L.T. & Axelrod, J.: Subcellular localization of
catecholamines in tissues of the rat. J. Pharmacol .
142:291-298,1963.

132

Prange, A.J. Jr., 'dilson, I.e., Lynn, C. W., Alltop, L.5. &
Stikeleather, R. A.: 1-Tryptophan in mania. Arch . Gen.
Psychiatr . 2Q_:56-62,1974.
Raab, \'/ . & Humphreys , R. J.: Drug action upon myocardial
epinephrine-sympathin concentration and heart rate.
J . Pharmacol . Exp. Ther . 89:64-76,1947.
Rajan, K. s., 'v 'liehle , R. D. , Riessen, W. H. , Colburn, R. W.
& Davis, J. M.: Effect of metal chelating agent s on the
storage of norpeinephrine in-vitro by cerebral synaptic
vesicles. Biochem. Pharmacol. 26:1703-1708,1977.
Roberts , D. V.: Enzyme Kinetics.
Pres s, New York 1-326,1977.

Cambridge University

Rosell, s., Kopin, I.J. & Axelrod, J.: Fate of H3 -noradrenaline in sketal muscle before and following
sympathetic stimulation. Am. J. Physiol. 205:317-321,
1963.
---Ross, S.3. & Renyi, A. L.: Blocking action of sympathomimetic amines on the uptake of tritiated noradrenaline
by mouse cerebral cortex tissues in-vitro. Acta .
Pharmacol . Toxicol . 21:226-239,1964.
~oss,

S . 3. & Renyi, A. L.: Uptake of some tritiated sympat~o
mimetic amines by mouse brain cortex slices in-vitro.
Acta. Pharmacol. Toxicol. 24:297-309 ,1966.

Ross, S. B. & Renyi , A. L.: Inhibition of the uutake of
tritiated catecholamines by antidepressant and related
agents. Europ. J. Pharmacol . ~:181-186,1967a.
Ross, S. 3 . & Renyi , A. L.: Tricyclic a_~tidepressant agents .
II. Effect of oral administration on the uutake of 53_
noradrenaline and c14_5-hydroxytryptamine ln slices of
the midbrain- hypothalamos region of the rat. Acta
Pharmacol . Toxicol . 36:395-408,1975b.
Roth, J . A. & Gillis, C. N.: Some structural requirements for
inhibition of type A and 3 forms of rabbit monoamine
oxidase by tricyclic psychoactive drugs. 1101. Pharmacol. J1:28-35,1974.
Rubin, R . P~ : The role of calcium in the release of neurotransmitter substances and hormones. Pharm. Rev. 22:
389-428,1970.
Salt, P .J.: Inhibition of noradrenaline uptake? in the
isolated rat heart by steroids, clonidine and
methoxylated phenylethylamines . Europ. J. Pharmacol .
20 :3 29-340,1972 .

Sayers, A. C. & Burki , H. R.: Antiacetylcholine activities
of psychoactive drugs: A comparison of the (3E) quinuclidinyl benzilate binding assay with conventional
methods . J. Pharm . Pharmacol . 28 : 252- 253,1976 .
Schildlcraut, J.J: The catecho lamine hypothesis of affective
disorders: A review of supporting evidence. Amer. J.
Psychiatr . 112:509-522,1965.
Schildkraut, J.J.: rorepinephrine metabolites as biochemical criteria for classifying depressive disorders and
predicting responses to treatment: Preliminary findings.
Amer . J. Psychiatr . 130:695-698,1973.
Schildkraut, J.J. & Kety , S.S.: Biogenic amines and
emotion. Science 156:21-30,1967.
Schmidt, H.S., Clark, R. W. & Hyman , P .R.: Protriptyline :
An agent effective in the treatment of the narcolepsycataplexy syndrome and hypersornnia. Amer. J. Psychiatr .
134:183-185,1977.
Schuberth, J.: Choline acetyltransferase: Purification and
effects of salts on the mechanism of the enzyme catalysed
reaction. Biochim . Biophys • . Acta 122:470-481,1966.
Schuberth , J. & Sundwall, A.: Effect of some drugs on the
uptake of acetylcholine in cortex slices of mouse
brain . J. Neurochem . 11.:807-812,1967.
Shaskan , E.G. & Snyder, S. H.: Kinetics of serotonin
accumulation into slices from rat brain: Relationship
to catecholamine uptake. J. Pharmacol . Exp. Ther .
175:404-418,1970.
Shein, K. & Smith, S . E.: Structure-ac tivity relationships
for the anticholinoceptor action of tricyclic antidepressants.
Brit . J. Pharmacol . 62 : 567- 571 ,1978 .
~

Shore, P.A.: rtelease of serotonin and catecholami~es by
drugs. Pharm . Rev . 11.:531-550,1962.
Sjoqvist, F., Taylor, P . W. Jr . & Titus, E.: The effects of
imiuunosympathectomy on the retention and metabolism of
noradrenaline. Acta Physiol . Sca~d. 69 :1 3- 22,1967 .
Snodgrass, S.R., Hedley-Whyte, E. T. and Lorenzo, A. V. :
GABA transport by nerve ending fractions of cat brain .
J. Neurochem . 20:771-782,1973.
Snyder, S . H., Bro'v'm, B. & Kuhar, M.J.: The synaptosomal
localization of histamine, histadine decarboxylase,
the histamine methyltransferase in rat hypothalamus .

134
J. Neurochem. 23:37-45,1974.
Snyder, S. H. & Coyle , J.T : Regional differences in H3norepinephrine and H3-dopamine uptake into brain
homogenates. J. Pharmacol. Exp. Ther. 165:78-86,1969.
Snyder, S. H., Glowinski , J. & Axelrod, J.: The storage of
norepinephrine and some of its derivatives in brain
synaptosomes. Life Sci. ±:797-807,1965.
Snyder, S. H., Green, A.I. & Hendley, E.D.: Kinetics of ~ 3norepinephrine accumulation into slices from dif1'erent
regions of the rat brain . J. Pharmacol . Exp . Ther .
164:90-102,1968.
Snyder, S. H., Logan , W.J., Bennett, J.P . & Arregui, A.:
Amino acids as central nervous transmitters: Bioche:nical studies. In Neuroscience Re search : Chemical
!Pproaches to Brain Function Ehrenpreis,
& Kopin ,
1.J. (eds.) Academic Press , New York 131-157,1973.

s.

Snyder, S. H. & Yammamura , n .I.: Antidepressants and the
muscarinic acetylcholine receptor. Archiv. Gen .
Psychiatr . 34:236-239,1977.
Stromblad, B.C.R. & Nickerson, M.: Accumulation of epinephrine and norepinephrine by some rat tissues .
J. Pharmacol . Exp . Ther . 134 :1 54-159,1961 .
Thoenen, H., Hurlimann, A. & Haefely, W.: The effect of
sympathetic nerve stimulation on volume, vascular
resistance and norepinephrine output in t h e isolated
perfused spleen of the cat and its modification by
cocaine. J. Pharmacol. Exp . Ther. 143:57- 63 ,1 964a.
Thoenen, H., Hurlimann, A. & .'.iaefely, .'l .: Wirkungen von
phenoxybenzamin, phentolamin und azapetin auf adrenergische synapse der katzenmilz . Helv. ?hysiol .
Pharmacol . Acta 22:148-161,1964b.
1

Tipton, K. F., f.J!antle, T.J. & Houslay, M. D.: A kinetic
method for the detection of inhibitory contaminants
in radioactive substrates. Biochem. Pharmacol .
26:1525-1527,1977.
Tissari, A.H . & Bogdanski, D.F.: Biogenic amine transport,
VI. Comparison of effects of ouabain and K+ deficiency
on the transport of 5-hydroxytryptamine and norepinephrine by synaptosomes. Pharmacology 5:225-234,1971.
Tseng , L. F. & Loh, H. H.: Significance of dopamine receptor
activity in methoxy-ampnetamine and d-amphetamineinduced locomotor activity. J. Pharmacol . Exp. Ther .
189:717-724,1974

13-5
Tseng , L. F., Hitzemann , R. J. & Loh, E . H.: Comparative
effects of d,1-p-methoxy-amphetamine and d-amphetamine
on catecholamine release and reuutake in-vitro.
J. Pharmacol . Exp. Ther . 189:708:716,1974.
Umbreit , W. W., Burris, R. H. & Stauffer , J. F.: r·1anometric
Techniques Fourth Edition Burgess Publ . Co. 132,1964.
1

Weil-Malherbe, H.: The biochemistry of affective disorders.
In Handbook of Neur ochemistry : Pathological Chemistry
of the Nervous System. Plenum Press, New York 371-416,

1972.

Wentworth , W. E.: Rigorous least squares adjustment: Application to some non-linear equations, I. J. Chem . Ed . 42 :
96-103,1965(a).
~
Wentworth , W. E.: Rigorous least squares adjustment: Applications to some non-linear equations, II. J. Chem . Ed .
42:162-167,1965(b).
L. G., Axelrod, J. & Weil- Malherbe, H.: The fate of
H -norepinephrine in animals. J. Pharmacol . Exp . Ther .
132:193-201,1961.

Whitby ~

White , T. D. & Keen , P .: Effects of inhibitors of (Na++
K+) -dependent adenosine triphosphatase on the uptake of
norepinephrine by synaptosomes. Mal. Pharmacol . ]: 4045,1971.
Wilkerson, rt..D .: Antiarrhythmic effects of tricyclic anti depressant drugs in ouabain induced arrhythmic in the
dog. J. Pharmacol . Exp. Ther . 205(3) : 666- 674 ,19 78 .
Wilkinson, G. N.: Statistical estimations in enzyme kinetics .
Biochem . J . 80:324-332 ,1961 .
Winer , B. J .: Statistical Principles in Experimental
D~ Second Edition McGraw- Hill, Inc., New York
'51-::-54'1971.
A . R. , Kuhar , M. J. & Snyder , S.H.: A unique synaptosomal fraction which accumulates glutamic and aspartic
acids in brain tissue. ?roe . Natl . Acad. Sci . 68 :11021106,1971.

~lofsey ,

Wolfe , D. E., Potter, L. T. and Webster, E. ~·: Radioantographic localization of norepinephrine- H in the tissues
of mice. J . Pharmacol . Exp . Ther . 138:376-381,1962.
Wong, D. T., Horng, J. S. and Fuller , R. W.: Kinetics of
serotonin accumulation into synaptosomes of rat braineff ects of amphetamine and chloroamphetamines. Biochern .

136

Pharmacol . 22:311-322,1973.
Wurtman , R. J . & Axelr od, J.: A sensitive and specific
assay for the estimation of monoamine oxidase. Biochem.
Pharmacol . 12:1439-1441,1963.
Wylie, D. N., Archer, S. & Arnold, A.: Augm entation of
pharmacological properties of catecholamines by 0methyl transferase inhibitors. J . Pharmacol. 130:239244,1960 .
Yamamurs, H. I . & Snyder , S . H.: Hi gh affinity transnort of
choline into synaptosomes of rat brain . J . Neurochem .
21 :1355 -1374 ,19 73 .
Yoshida , H., Namba, J ., Kaniik e, K. & Imaizumi, R.: Studies
on the active transport of 1-dopa (dihydroxy-pheny lalanine) into brain slices. Jap . J. Pharmacol. 13: l9,1963a.
~
Yoshida , H., Kaniike, K. & Namba, J .: Inhibitions by ouabain
and protoveratrine on active transport of 1-dopa into
brain slices. Jap. J. Pharmacol. 13:10-17,1963b.
Yoshida , H., Kaniike, K. & Namba , J .: Properties of a
carrier system to transport 1-dopa into brain slices.
Nature 198 (4876):191-192,1963c.
Yoshida , H., E¥ji~awa, H. & Ohi, Y.: Influences of protanine
on the Na , K -dependent ATP- ase and on the active transport processes of potassium and of 1-dopa into brain
slices. Can . J. Biochem. 43:841- 849 ,19 65.
Young, A. B., Pert, C. D. , Brown, D. G., Taylor, K. M. &
Snyder, S . H.: Nuclear localization of histamine in
neonatal rat brain . Science 173:247-249,1971.
Zaimis , E., Berk, L. & Callingham, B.: Morphological biochemical and functional changes in the sympathetic
nervous system of rats treated with NGF-antiserum .
Nature 206:1221-1222,1965.
Zigmond, M. J. , Chalmers, J. P ., Simpson, J. R. & Wurtman,
R . J.: Effect of lateral hypothalamic lesions on
uptake of norepinephrine by brain homogenates . J.
Pharmacol . Exp. Ther. 179:20-28,1971.

137

AFP Sl~ DIX

138

Figure A-1.

Flbwc hart for "VIVO ": A program used to
calculate data for synaptosomal uptake studies

ST&.qT

I NPUT
DATA

no
CALCULATE
unadjusted
P/ M & l/P

PRINT
unadjus •
P/M&l/

FINISH

CALCULATE
adjusted
P/M , l/P &
mg . protei

PRINT
adj. P/ M
l/P &
• nrot .

FINISH
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Table A-1.
vivo
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260
270
280
290
300
310
3 20
330
340
350
360
370
' 380
390
400.
410
420
430
440
450
460
Ii

70

480
490
500
510
520
530
540
550
560
570

Listing of 'VIVO': A program used to calculate data for synaptosomal uptake studies.
'15:47

sun

2 3 j an 7 7

dlm z(lOO), 1 (100), m(lOO), n(100), q(lOO)
dim .r(lOO), g(SO), h(SO), j(lOO), y(100)
dim i(lOO), s(lOO), w(lOO), p(lOO), e(100)
dim a(lOO), b(lOO), c(l00), d(l00), f(100), t(l00)
print 'experiment number?'
Input n$
print
print 'specify n (where n =I of reaction vessels):',
Input n
print
print 'enter cpm data, in order, from the 1 !quid'
print 'scintillation spectrometer printout.'
print 'enter each value Individually by pressing'
print 'the return key after each entry.'
print
print '37 degrees; serotonin; Incubation media values'
for k = 1 to n/6
Input l(k)
next k
print
print 1 37 de~rees; noreplnephrlne; incubation media values'
for k = n/6+1 to n/3
i n put I ( k)
next k
print
print 1 37 degrees; dopamlne; Incubation media values'
for k = n/3+1 to n/2
Input l(k)
next k
print
prlnt " '37 degrees; serotonin; supernatant ·values'
for k = 1 to n/6
input s(k)
next k
print
print '37 degrees; norepinephrtne; supernatant values'
for k = n/6+1 to n/3
i np U t S ( k )
next k
print
print '37 degrees; dopamine; supernatant values'
for k = n/3+1 to n/2
input s(k)
next k
prlnt
print 1 37 de~rees; serotonin; wash values'
for k = 1 to n/G
input w(k)

580 next k
590 print
600 print 1 37 de~rees; norepfnephrine; wash values'
610 for· k = n/6+1 to n/3
620 input w(k)
630 next k
640 print
650 print 1 37 degrees; dopamine; wash values'
660 for k = n/3+1 to n/2
670 input vdk)
680 next k
690 print
700 print 1 37 degrees; serotonin; pellet values'
710 for k = 1 to n/5
720 input p(k)
730 next k
740 print
750 print 1 37 degrees; norepinephrine; pellet values'
760 for k = n/6+1 to n/3
770 input p(k)
780 next k
790 print
800 print ''7 degrees; dopamine; pellet values'
810 for k = n/3+1 to n/2
820 Input p(k)
830 next k
,
840 print
850 print 'zero degrees; serotonin; incubation media values'
860 for k = n/2+1 to 2*n/3
870 input i(k)
380 next k
890 print
900 print 'zero de~rees; norepinephrine; incubation media values'
910 for k = 2*n/3+1 to 2*n/3+n/E
920 input I (k)
930 next · k
940 print
950 print 'zero degrees; dopamine; Incubation media values'
960 for k = 2*n/3+ri/6+1 to n
970 Input i (k)
980 next k
990 print
1000 print 'zero degrees; serotonin; supernatant values'
1010 for k = n/2+1 to 2*n/3
1020 input s(k)
1030 next k
1040 print
1050 print 'zero de~rees; noreplnephrine; supernatant values'
1060 for k = 2*n/3+1 to 2*n/3+n/6
1070 inout s(k)
1080 next k
1090 print
1100 print 'zero de~rees; dopamine; supernatant values'
1110 for k = 2*n/3+n/6+1 to n
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1120
1130
1140
1150
1150
1170
1180
1190
1200
1210

Input s(k)
next k
print
pri.nt 'zero degrees; serotonin; wash values'
for k = n/2+1 to 2*n/3
input w(k)
next k
print
print 'zero de?,rees; noreplnephrine; wash values'
for k = 2*n/3+1 to 2*n/3+n/6

1 2 2 0 I n pu t w ( k )

1230
1240
1250
1260
1270
1280
1290
1300
1310
1320
1330
1340
1350
1360
1370
1380
1390
1400
1410
1420
1430
1440
1450
1460
1470
1480
1490
1500
1510
1520
1530
1540
1550
1560
1570
1580
1590
1600
1610
1620
1630
1640
1650

next k
print
print 'zero degrees; dopamine; wash values'
for k = 2*n/3+n/6+1 to n
input w(k)
next k
print
.
print 'zero degrees; serotonin; pellet values'
for k = n/2+1 to 2*n/3
Input p(k)
next k
print
print 'zero degrees; norepinephrlne; pellet values'
for k = 2*n/3+1 to 2*n/3+n/6
input p(k)
riext k
print
print 'zero degrees; dopamine; pellet values'
for k = 2•n/3+n/6+1 to n
input p(k)
next k
print
print 'were there any changes in the experimental design?'
input a$
If ~$ = 'no' then 1640
if a$ = 'yes 1 then 1490
print
print 'enter the following values:'
print ;'incub. med. vol. (ml.), its sample aliquot (ml.): 1
Input fl, #2
print ;'wash vol. (ml.), its sample aliquot (ml.):'
input 13, #4
print ; 'pet let (sol. vol.Isam. vol.):'
input #5
print ;'sup. sample aliquot (ml.):'
input 16
print ;'brain homogenate sample volume (ml.):'
input 18
#7 = ll - 12
print
go to 1730
#l = 4.0
12 = 0.1
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1660 13 = 6.0
1670 1i. = 0.1

1680 15
1690 16
1700 17

=
=
=

1.575
0.1
3.9

1710 18 = 0.2
1720 print
1730 def fna(k) = p(k) * 15
1740 def ·fnr(k) = int(l0**6/fna(k))/100
1750 def fnb(k) = w(k) * #3/#4
1760 def fnc(k) = s(k) * 17/#6
1770 def fnd(k) = (fnc(k) + fnb(k))/#7
1780 def fne(k) = int(-10**4*(i (k)*#l/#2 - (fna(k)+fnb(k)+fnc(k
)))/(i(k)*#l/#2))/100
1790 def fnf(k) = int(l0**5*fna(k)/fnd(k))/l00
1800 print
1810 print 'do you have the results of the protein assay?'
1e20 input c$
1830 if c$ = 'yes' then 2220
1840 print 'pause for paper Insertion-press return key when rea
dy'
1850 pause
1860 print, 'experiment I', n$
1870 print
1880 print
1890 pr Int ,,;;;;'unadjusted'
1900 print ;;'sample no.';;;'% error';;;;'p/m 1 , 1 l/p 1
1910 print , , I (exp- 3) I , I (exp- 4) I
l!J20 print
1930 print ,'37 degrees'
1940 print
1950 for k = 1 to n/6
1960 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
1970 next 1<
1980 for k = n/6+1 to n/3
1930 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
2000 next k
20Hl print
2020 for k = n/3+1 to n/2
2030 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
2040 next k
2050 pr Int
2060 print ,'zero degrees'
2070 print
2080 for k = n/2+1 to 2*n/3
2090 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
2100 next k
2110 print
2120 for k = 2*n/3+1 to 2*n/3+n/G
2130 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
2140 next k
2150 print
2160 for k = 2•n/3+n/6+1 to n
2170 print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k)
2180 next k
2190 print
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2200 go to 3410
2210 print
2220 print 'enter the results of the protein assay In the form'
2230 print 1 (m,b,al,sl,a2,s2, ••• an,sn) where m and bare the'
2240 print '.lowry re3ression coeff lcient an1 Intercept, respect
Ive 1 y; ' ·
2250 print 'al to an are the absorbances and sl to snare their
respective'
2260 print 'sample sizes (ml.) used to obtain val Id absorbance
readln~s'

2270 print 'beginning with l=forebraln control, 2=1ow dose, 3=1
O'r'J-med, 1
2280 print '4=hi-med and 5=hi dose; 6-10 represent hypothalamus
control to'
2290 print 'hi dose samples and finally 11-15 are strlatal valu
es. '
2300 print ;;'Center 2 values per line)'
2310 print
2320 input m,b
2330 prf nt
2340 for k = 1 to n/2
2350 input g(k),h(k)
2'360 next k
2370 def fnj(k) = lgt(g(j))
2330 def fny(k) = (fnj(k)-b)/rn
2390 dim k{100)
2400 def fnk(k) = lnt{lOOO*{fny(k)*l8/h{j)/l0**3))/1000
2410 def fnl (k) = fna{k)/fnk(k)
2420 def fnm(k) = fnl (k)/fnd(k) ·
2430 def fnn(k) = 10**5/fnl Ck)
2440 print 'pause for paper insertion-press return key when rea
dy'
2450 pause
2460 print , 'experiment I ' ,n$
. 24 70 print
2480 print
' lowry adjusted'
2490 print
2500 print 'sample no '····~error'···· 'p/m' · · ·' l/p', 'mg. pro
I
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2510
25 20
2530
2540
2550
2560
2570
2580
25 90
2600
2610
2620
2630
2640
2650
2660
2670

print ,;;;;' (exp-3)';;' (exp-5)'
def fnq(k) = lnt{l0**5*fnm{k))/100
def fnt(k) = lnt{l0•*2*fnn(k))/100
dim o(30)
dim u(30)
print
print , 1 37 degrees'
print
for k = 1 to n/6
let j = k
print ;k;;;fne(k);;;fnq{k);;;fnt(k);;;fnk(k)
let o(k) = fnq(k)
let u(k) = fnt{k)
next k
print
for k = n/6+1 to n/3
let j = k
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2680 print ;k;;;fne(k);;;fn~(kl;;;fnt(k);;;fnk(k)
2690 let o(k) = fnq(k)
2700 let u(k) = fnt(k)
2710 next k
2720 pr l.n t
2730 for k = n/3+1 to n/2
2740 let j = k
2750 print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k)
2760 let o(k) = fnq(k)
2770 let u(k) = fnt(k)
2730 next k
2790 print
2800 print , 'zero degrees'
2810 print
2820 for k = n/2+1 to 2•n/3
2830 let j = k-15
2840 print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k)
2350 let o(k) = fnq(k)
2860 let u(k} = fnt(k)
2870 next k
2880 print
2290 for k = 2•n/3+1 to 2•n/3+n/6
2900 let j = k-15
2910 print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k)
2920 let o(k) = fnq(k)
2930 let u(k) = fnt(k)
2940 next k
2950 print
2960 for k = 2•n/3+n/6+1 to n
2970 let j = k-15
2980 print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k)
29 90 let o(k) = fnq(k)
3000 let u(k) = fnt(k)
3010 next k
3020 print
3030 print 'do you wish to print p/m corrected for'
3040 pr Int 'non-specific absorption?'
3050 input d$
30GO if d$ = 'yes' then 3080
3070 if d$ = 'no' then 3410
3080 print 'pause for paper insertion-press return key when rea
dy'
3090 pause
3100 print ,'experiment 1 1 ,n$
3110 print
3120 print 'values reported are adjusted for non-specific absor
pt ion'
3130 print
3140 print ;;;,'p/m'
3150 print ;;; 'Cexp-3)(cpm/mg. proteln)/(cpm/ml. sup.)'
3160 print
3170 print 'serotonin'
3180 print
3190 for k = 1 to n/6
3200 let j = k+lS

145

3210
3220
3 23 0
3 24 0
3250
3260
3270
3280
3290
3300
3 3 J. 0
3320
3330
3340
3350
3360
3370
3380
3390
3400
)410

pr Int ,;;o(k)-o(j)
print
next k
print
print 1 noreplnephrlne'
print
for k a n/ 6+1 to n/3
let J = k+l5
print , ; ;o(k)-o(j)
pr Int
next k
print
print 'dopamine'
pr Int
for k = n/3+1 to n/ 2
let J = k+lS
print , ; ;o(k)-o(j)
print
next k
print
end
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